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Abstract—In 2004, the first American Heart Association scientific statement on “Air Pollution and Cardiovascular
Disease” concluded that exposure to particulate matter (PM) air pollution contributes to cardiovascular morbidity and
mortality. In the interim, numerous studies have expanded our understanding of this association and further elucidated
the physiological and molecular mechanisms involved. The main objective of this updated American Heart Association
scientific statement is to provide a comprehensive review of the new evidence linking PM exposure with cardiovascular
disease, with a specific focus on highlighting the clinical implications for researchers and healthcare providers. The
writing group also sought to provide expert consensus opinions on many aspects of the current state of science and
updated suggestions for areas of future research. On the basis of the findings of this review, several new conclusions
were reached, including the following: Exposure to PM 2.5 m in diameter (PM2.5) over a few hours to weeks can
trigger cardiovascular disease–related mortality and nonfatal events; longer-term exposure (eg, a few years) increases
the risk for cardiovascular mortality to an even greater extent than exposures over a few days and reduces life expectancy
within more highly exposed segments of the population by several months to a few years; reductions in PM levels are
associated with decreases in cardiovascular mortality within a time frame as short as a few years; and many credible
pathological mechanisms have been elucidated that lend biological plausibility to these findings. It is the opinion of the
writing group that the overall evidence is consistent with a causal relationship between PM2.5 exposure and
cardiovascular morbidity and mortality. This body of evidence has grown and been strengthened substantially since the
first American Heart Association scientific statement was published. Finally, PM2.5 exposure is deemed a modifiable
factor that contributes to cardiovascular morbidity and mortality. (Circulation. 2010;121:2331-2378.)
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In 2004, the American Heart Association (AHA) publishedits first scientific statement regarding air pollution and
cardiovascular disease (CVD).1 The rationale was to provide
researchers, healthcare providers, and regulatory agencies
with a comprehensive review of the evidence linking air
pollution exposure with cardiovascular morbidity and mor-
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tality. There was also an explicit aim to educate clinicians
about the importance of this issue, because the cardiovascular
health consequences of air pollution generally equal or
exceed those due to pulmonary diseases.1–4 Finally, a list of
key remaining scientific questions and strategic avenues for
investigation were provided to help foster and guide future
research.
The first AHA writing group concluded that short-term
exposure to particulate matter (PM) air pollution contributes
to acute cardiovascular morbidity and mortality1 and that
exposure to elevated PM levels over the long term can reduce
life expectancy by a few years. Although some mechanistic
details remained incompletely described, the existing science
was deemed adequate to substantiate several plausible bio-
logical pathways whereby PM could instigate acute cardio-
vascular events and promote chronic disease.
There is mounting evidence from a rapid growth of
published data since the previous statement related to the
harmful cardiovascular effects of air pollution.3,4 Most, but
not all, epidemiological studies corroborate the elevated risk
for cardiovascular events associated with exposure to fine PM
2.5 m in aerodynamic diameter (PM2.5). PM2.5 generally
has been associated with increased risks of myocardial
infarction (MI), stroke, arrhythmia, and heart failure exacer-
bation within hours to days of exposure in susceptible
individuals. Several new studies have also demonstrated that
residing in locations with higher long-term average PM levels
elevates the risk for cardiovascular morbidity and mortality.
Some recent evidence also implicates other size fractions,
such as ultrafine particles (UFPs) 0.1 m, gaseous copol-
lutants (eg, ozone and nitrogen oxides [NOx]), and specific
sources of pollution (eg, traffic). In addition, there have been
many insights into the mechanisms whereby PM could prove
capable of promoting CVDs.2–4 Air pollutants have been
linked with endothelial dysfunction and vasoconstriction,
increased blood pressure (BP), prothrombotic and coagulant
changes, systemic inflammatory and oxidative stress re-
sponses, autonomic imbalance and arrhythmias, and the
progression of atherosclerosis. In the interim, the US Envi-
ronmental Protection Agency (EPA) completed its updated
“Air Quality Criteria for Particulate Matter”5 and afterward
strengthened the National Ambient Air Quality Standards
(NAAQS) for daily PM2.5 levels starting in 2006 (down from
65 to 35 g/m3).6 The most recent scientific review coordi-
nated by the EPA, the final report of the Integrated Science
Assessment for Particulate Matter (http://cfpub.epa.gov/ncea/
cfm/recordisplay.cfm?deid216546), has also been made
available publicly. These numerous changes and advances
provide the rationale for the present updated AHA scientific
statement on PM air pollution and CVD. This updated
statement is similar in scope, content, and overall structure to
the first document; however, it provides many additional
conclusions and recommendations that can now be made
because of the expanded number and quality of studies.
Objectives and Methods
The primary objective of this scientific statement is to
provide a comprehensive updated evaluation of the evidence
linking PM exposure with CVDs. The focus of this review is
explicitly on PM because the majority of air pollution studies
have centered on its cardiovascular effects, and the strength
of the evidence makes it possible to provide consensus
opinions and recommendations. Except for in a few circum-
stances, such as when copollutants have been shown to (or
not to) modify the responses to PM exposure or to have
independent cardiovascular effects in epidemiological studies
of major importance, a detailed discussion of other air
pollutants (eg, ozone and NO2) is beyond the scope of this
document. Additional objectives are to provide expert con-
sensus opinions on aspects related to the current state of
science, to specifically highlight the health and clinical
implications of the reviewed findings, and to provide prudent
and practical recommendations for measures to reduce PM
exposure that might thereby lower the associated cardiovas-
cular risk. This updated scientific statement is structured to
first provide a clinical perspective on the cardiovascular risks
posed by PM exposure and then briefly review the compo-
nents of air pollution. The following sections highlight the
major findings from epidemiological studies, including mor-
tality, morbidity, and surrogate outcome results. Next, the
animal and human mechanistic studies are reviewed, and an
overall framework whereby PM exposure could cause CVDs
is outlined. Finally, updated consensus opinions and conclu-
sions are provided, followed by suggestions for areas of
future research and policy considerations.
Members of the current writing group were selected from
across a broad range of disciplines, including cardiovascular
and environmental epidemiology and statistics, atmospheric
sciences, cardiovascular and pulmonary medicine, basic sci-
ence research, and public policy. The writing group identified
studies published in the English language between January 1,
2004, and March 31, 2009, by a World Wide Web–based
literature search using Medline, PubMed, and Google search
engines. Key terms included air pollution or particulate
matter plus any of the following: cardiovascular, myocardial,
heart, cardiac, stroke, heart failure, arrhythmia, heart rate
variability, autonomic, sympathetic, atherosclerosis, vascu-
lar, blood pressure, hypertension, diabetes, metabolic, throm-
bosis, and coagulation. Additional studies were identified
within the references of these publications and by the per-
sonal knowledge of the writing group members. A few
studies published after March 31, 2009, were added during
the review process. All of the identified epidemiological
studies that provided mortality data or hard cardiovascular
outcomes (eg, MIs) and controlled human exposure protocols
were included. In a few circumstances, studies before 2004
were included briefly in the discussion or tables when it was
believed that they provided contextual background and/or
relevant findings from earlier analyses of ongoing studies (eg,
Harvard Six Cities and American Cancer Society [ACS]
cohorts) from which new results after 2004 have been
published. It is a limitation of the present review that it was
not possible to cite all surrogate outcome human studies
because of the enormous number of publications. Some were
not included, without intentional bias with regard to results,
when multiple referenced studies demonstrated similar find-
ings. In such a situation (eg, heart rate variability [HRV]), this
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limitation was noted within the specific section. A main
theme of the present statement is to provide clinical context
and recommendations for healthcare providers, and thus, it
was beyond the scope and not the intent of this document to
include all animal, ex vivo, or toxicological studies. A
number of these publications were also not included, without
intentional bias with regard to results. The writing group
included publications that were believed to have relevant
implications for human cardiovascular health, those that
formed the foundation of the mechanistic hypotheses, and
studies that were deemed of major importance. Finally, the
“evidence summary” statements and all points in the conclu-
sions and recommendations represent consensus expert opin-
ions agreed on by all members of the writing group during
formal discussions. It is explicitly stated when no such
agreement was reached. These statements and the points
within Tables 6 and 7 do not represent the result of applying
the standard AHA criteria (ie, level and class) to the sum
findings of the present review, because those do not apply,
but rather the qualitative consensus opinions agreed on by the
writing group. The purpose is to provide expert opinions on
the comparative relative ranking and the strength of the
overall evidence regarding different areas within this field of
science.
Perspective on the Air Pollution–
Cardiovascular Risk Association
Traditional cardiovascular risk factors account for the major
portion of the risk for ischemic cardiac events within a
population.7 Individuals with optimal levels of all risk factors
have been shown to have a low lifetime cardiovascular event
rate.8 Thus, control of the traditional risk factors is recognized
to be of paramount importance to prevent CVDs. In this
context, there has been some debate about the overall clinical
relevance and utility of adding novel risk factors to risk-
prediction models to incrementally improve their overall
predictive value, even when assessed by multiple methodol-
ogies.9 On the other hand, the ability to predict future events
by existing models remains imperfect. In addition to several
mathematical and statistical explanations for this shortcom-
ing,10,11 it is important to recognize that the development of
vascular or atherosclerotic disease (the factor predicted by
most statistical models) is usually a necessary but insufficient
cause of future ischemic events in and of itself. Cardiovas-
cular events must also be triggered by an additional factor at
some unknowable future time, and therefore, they transpire as
a stochastic process within a population.12 This is one of
several reasons why PM air pollution is a uniquely important
public health issue among the list of novel risk factors; PM
inhalation is an established trigger of cardiovascular events
that occur within hours to days after exposure.12 Because of
the ubiquitous and involuntary nature of PM exposure, it may
continuously enhance acute cardiovascular risk among mil-
lions of susceptible people worldwide in an often inconspic-
uous manner. Moreover, beyond serving as a simple trigger,
PM elicits numerous adverse biological responses (eg, sys-
temic inflammation) that, in premise, may further augment
future cardiovascular risk over the long term after months to
years of exposure.
Effects of Short-Term Exposure
Time-series studies estimate that a 10-g/m3 increase in
mean 24-hour PM2.5 concentration increases the relative risk
(RR) for daily cardiovascular mortality by approximately
0.4% to 1.0%.3 Despite theoretical statistical risks ascribed to
all individuals, this elevated risk from exposure is not equally
distributed within a population. At present-day levels, PM2.5
likely poses an acute threat principally to susceptible people,
even if seemingly healthy, such as the elderly and those with
(unrecognized) existing coronary artery or structural heart
disease.13 Therefore, the absolute risk rather than the RR of
exposure may more effectively convey the tangible health
burden within a population. A 10-g/m3 increase during the
preceding day contributes on average to the premature death
of approximately 1 susceptible person per day in a region of
5 million people (based on annual US death rates in 2005).3,14
Although the dangers to 1 individual at any single time point
may be small, the public health burden derived from this
ubiquitous risk is enormous. Short-term increases in PM2.5
levels lead to the early mortality of tens of thousands of
individuals per year in the United States alone.1,3,5
Effects of Long-Term Exposure
Cohort studies estimate that the RR associated with living in
areas with higher PM levels over the long term is of greater
magnitude than that observed from short-term exposure
increases (RR between 1.06 and 1.76 per 10 g/m3 PM2.5).3
In this context, the World Health Organization estimated that
PM2.5 contributes to approximately 800 000 premature deaths
per year, ranking it as the 13th leading cause of worldwide
mortality.15 Hence, PM air pollution appears to be an impor-
tant modifiable factor that affects the public health on a
global scale.
Air Pollution
The first AHA statement on air pollution reviewed the size
fractions, sources, and chemical constituents of PM and the
main gaseous air pollutants: Nitrogen oxides (NOx; ie,
NONO2), carbon monoxide (CO), sulfur dioxide (SO2), and
ozone (O3).1 Therefore, this section within the updated
statement focuses on several other contemporary aspects of
air pollution characterization and exposure assessment, par-
ticularly in relation to their potential influences on cardiovas-
cular health. In brief, PM is broadly categorized by aerody-
namic diameter: All particles 10 m (thoracic particles
[PM10]), all particles 2.5 m (fine particles [PM2.5]), all
particles 0.1 m (UFP), and particles between 2.5 and
10 m (coarse particles [PM10–2.5]). Hence, PM10 contains
within it the coarse and PM2.5 fractions, and PM2.5 includes
UFP particles. The concentrations of PM10 and PM2.5 are
typically measured in their mass per volume of air (g/m3),
whereas UFPs are often measured by their number per cubic
centimeter (Table 1). The major source of PM2.5 throughout
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the world today is the human combustion of fossil fuels from
a variety of activities (eg, industry, traffic, and power gener-
ation). Biomass burning, heating, cooking, indoor activities,
and nonhuman sources (eg, fires) may also be relevant
sources, particularly in certain regions.
Common air pollutants and those designated as EPA
criteria pollutants (ie, specifically targeted in regulations
through limits on emissions or government standards such as
the NAAQS) are listed in Table 1. The World Health
Organization also provides ambient guidelines (http://www.
euro.who.int/Document/E90038.pdf). As a result, many pol-
lutant concentrations are tracked in the United States by
nationwide monitoring networks, with up to approximately
1200 sites for O3 and PM2.5. Data are archived by the EPA
and are available to the public (http://www.epa.gov/ttn/airs/
airsaqs/). O3 levels exceed the national standard in many
areas, and thus, daily information is provided to assist the public
in reducing their exposure. A lower standard for ozone concen-
trations was proposed recently, which will lead to more frequent
occurrences of outdoor exposures deemed to be excessive (Table
1). The reporting of PM2.5 is also becoming common because of
its impact on public health and frequent violations of standards.
Current and forecast air quality indices and information on both
PM2.5 and ozone are available (http://airnow.gov/). At the end of
2008, 211 US counties (or portions of counties) were in
nonattainment of the 2006 daily PM2.5 NAAQS (http://www.
epa.gov/pmdesignations/2006standards/state.htm). On a positive
note, the various regulations that have been established have led
to substantial reductions in PM and other pollutant levels over
the past 40 years in the United States and contributed toward
similar improvements in other countries. However, reducing the
levels of some pollutants, such as O3, remains a challenge
because of the complex chemical processes that lead to their
formation in the atmosphere.16 The population of many devel-
oping nations (China, India, Middle Eastern countries) continues
to be exposed to high levels, particularly of PM, which can
routinely exceed 100 g/m3 for prolonged periods (http://
siteresources.worldbank.org/DATASTATISTICS/Resources/
table 3_13.pdf).
Air Pollution Mixtures, Chemistry, and Sources
Detailed information regarding PM sizes, composition, chem-
istry, sources, and atmospheric interactions is beyond the
scope of this document but can be found in the 2004 US EPA
Air Quality Criteria for Particulate Matter final report (http://
cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid87903). The
source for much of the information provided in this brief
summary is this document, unless otherwise specifically
referenced. The typical range of ambient concentrations for
several air pollutants in the United States, including the latest
US NAAQS for the criteria pollutants, is given in Table 1.
Classification of air quality according to 1 single pollutant
and by size or mass provides an incomplete picture, because
ambient air pollution is a complex mixture of gases, particles,
and liquids that are continually changing and interacting with
each other and natural atmospheric gases. Although PM2.5
mass has rightfully attracted considerable attention as a target
for regulation and epidemiological study, more than 98% of
Table 1. Ambient Air Pollutants
Pollutant US Average Range
US Typical
Peak*
Most Recent
NAAQS for Criteria
Pollutants
(Averaging Time)
O3† 0–125 ppb 200 ppb 75 ppb (8 h)‡
NO2† 0.5–50 ppb 200 ppb 100 ppb (1 h)§
53 ppb (Annual
mean)
NO† 0–100 ppb 200 ppb
SO2† 0.1–50 ppb 150 ppb 140 ppb (24 h)
30 ppb (Annual
mean)
CO† 0.1–5 ppm 20 ppm 35 ppm (1 h)
9 ppm (8 h)
PM10¶ 10–100 g/m
3 300 g/m3 150 g/m3 (24 h)#
PM2.5¶ 5–50 g/m
3
(Mean13.45.6)
100 g/m3 15 g/m3 (Annual
mean) 35 g/m3
(24 h)**
PM2.5 lead¶ 0.5–5 ng/m
3 150 ng/m3 0.15 g/m3
(Rolling 3-month
average)††
NH3† 0.1–20 ppb 100 ppb
HNO3† 0–5 ppb 10 ppb
Methane† 1–2 ppm 5 ppm
Formaldehyde† 0.1–10 ppb 40 ppb
Acetaldehyde† 0.1–5 ppb 20 ppb
NMHC (VOC)¶ 20–100 g/m3 250 g/m3
Propane¶ 2–20 g/m3 500 g/m3
Benzene¶ 0.5–10 g/m3 100 g/m3
1,3-Butadiene¶ 0.1–2 g/m3 10 g/m3
Total suspended
particles¶
20–300 g/m3 1000 g/m3
PM10–2.5¶ 5–50 g/m
3 200 g/m3
Sulfate¶ 0.5–10 g/m3 30 g/m3
Nitrate¶ 0.1–5 g/m3 20 g/m3
Organic carbon¶ 1–20 g/m3 30 g/m3
Elemental
carbon¶
0.1–3 g/m3 10 g/m3
PAH¶ 2–50 ng/m3 200 ng/m3
UFP† 1000–20 000/cm3 100 000/cm3
ppb Indicates parts per billion; ppm, parts per million; and PAH, polycyclic
aromatic hydrocarbon.
*Generally not in concentrated plumes or locations of direct source emission
impact.
†Typical hourly average concentrations reached in US cities.
‡The 8-hour standard is met when the 3-year average of the 4th highest
daily maximum 8-hour average is less than or equal to the indicated number.
In January 2010, the EPA proposed a more stringent 8-hour standard within the
range of 60 to 70 ppb (http://www.epa.gov/air/ozonepollution/actions.html).
§To attain this standard, the 3-year average of the 98th percentile of the daily
maximum 1-hour average at each monitor within an area must not exceed this value.
The level is not to be exceeded more than once per year.
¶Typical 24-hour average concentrations.
#The level is not to be exceeded more than once per year on average over 3 years.
**The daily standard is met when the 3-year average of the 98th percentile
of 24-hour PM level is less than or equal to the indicated number.
††Although the typical concentrations shown in the table are for PM2.5, the
lead standard continues to be based on measurements in total suspended
particulate.
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the air pollutant mass in the mixture we breathe in urban
settings is from gases or vapor-phase compounds such as CO,
nonmethane hydrocarbons or volatile organic carbons
(VOCs), NO2, NO, O3, and SO2. Each of these can have
independent and potentially synergistic or antagonistic effects
with each other and with PM; however, at present, the
cardiovascular health impact of exposure to combinations of
air pollutants is not well understood.
Most of the studies linking CVDs with PM exposures have
focused on particle mass; thus, this association is evaluated
and reported in the majority of epidemiological and toxico-
logical studies reviewed. Although PM is regulated by mass
concentration, the aspect of PM most harmful to cardiovas-
cular health may not be best quantified by mass measurement
alone. The sum effect of many features related to chemical
composition and size/morphology (eg, oxidative stress poten-
tial, solubility, charge, surface area, particle count, lung
deposition, and stability within the atmosphere and biological
tissues) is important to consider. With regard to specific
“toxic” compounds within PM, several lines of existing
evidence support the idea that transition metals, organic
compounds, semiquinones, and endotoxin are likely relevant
in relation to promoting CVDs. In addition, certain charac-
teristics of UFPs (eg, high surface area, particle number,
metal and organic carbon content) suggest that they may pose
a particularly high cardiovascular risk after short-term expo-
sure.17 Both the additional characterization of “criteria”
pollutants and the measurement of several other pollutants
(discussed below) are important to inform air quality man-
agement practices that involve air quality modeling, as well
as epidemiological studies and risk assessment, which ulti-
mately aim to improve risk-reduction strategies.
In addition to their mass concentration, pollutants can be
characterized on the basis of their origin or chemical and
physical properties. In terms of origin, nitrogen oxides
(NONO2), CO, SO2, and PM2.5, as well as carbon dioxide
(CO2), are mainly associated with combustion of fuel or other
high-temperature industrial processes. Combustion PM is
composed of many chemical compounds, including organic
carbon species, elemental or black carbon, and trace metals
(eg, lead and arsenic). They range in size from molecular
clusters a few nanometers in diameter to light-scattering
particles that peak on a mass contribution basis in the
diameter range of 200 to 1000 nm (0.2 to 1 m). UFP
numbers are also strongly linked to fresh combustion and
traffic-related pollution. Ammonia, methane, pesticides (per-
sistent organic pollutants), reduced sulfur compounds, resus-
pended dust, and natural coarse particles (PM10–2.5) are
associated with noncombustion surface or fugitive releases
that arise from a variety of human (eg, agriculture) and
natural (eg, erosion) activities. Agricultural emissions and
releases from a range of industrial processes and waste
management are also important sources. Road and wind-
blown dust from agricultural practices and from certain
industrial facilities (eg, mineral industry) also contribute to
these particles, which are typically in the coarse (PM10–2.5) or
even larger (PM10) range.
In addition to pollutants formed directly by combustion,
many others are produced primarily through chemical reac-
tions in the atmosphere among directly emitted pollutants.
These are known as secondary pollutants. Sunlight, water
vapor, and clouds are often involved in this atmospheric
chemistry, which leads to greater oxidation of the pollutants.
Examples include PM-associated sulfate, nitrate, and ammo-
nium and many of the organic compounds within PM2.5.
Besides O3, which is the most prevalent secondary gaseous
oxidant, a number of inorganic and organic acids and VOCs
form in the atmosphere. Examples are the hydroxyl radical,
peroxyacetyl nitrate, nitric acid, formic and acetic acid,
formaldehyde, and acrolein.
VOCs and semivolatile organic compounds (SVOCs), the
latter of which are found in both the gas and particle phase, are
an additional large class of pollutants. They are associated with
both combustion and fugitive emissions, as well as with second-
ary formation. Key examples are benzene, toluene, xylene,
1,3-butadiene, and polycyclic aromatic hydrocarbons. VOCs are
among the 188 hazardous air pollutants listed by the EPA, and
their main emission sources have been identified and are
regulated (http://www.epa.gov/ttn/atw/mactfnlalph.html).
VOCs can undergo reactions that convert toxic substances to
less toxic products or vice versa. Many VOCs contribute to
the formation of O3 and are oxidized in the atmosphere,
becoming SVOCs, and subsequently partition within particles
and contribute to the composition of PM2.5, as well as to its
mass. A great deal of research has focused on PM2.5 in the
past decade, which has led to advances in measurement
technologies18 and greater understanding of its chemistry and
atmospheric behavior.19 Nonetheless, understanding is in-
complete, particularly with regard to formation of the sec-
ondary organic fraction, the relative role of anthropogenic
and biogenic emissions to organics, surface chemistry, oxi-
dative potential,20 and gas-to-particle partitioning.
An alternative to attempting to identify one by one which
pollutant(s) or chemical compounds are most harmful is to
focus on identifying the sources, which typically emit mix-
tures of pollutants, of greatest concern. It may be the mixture
of pollutants (along with the source from which it is derived,
which determines its characteristics) that is most pertinent to
human health outcomes. Such information may actually be
more relevant for aiding the development of effective air
quality policies. One important example reviewed in the
epidemiology section is that the evidence continues to grow
regarding the harmful cardiovascular effects of traffic-related
pollution. Traffic is ubiquitous in modern society, with a
sizeable proportion of the population, particularly persons
disadvantaged by low socioeconomic status, living close
enough (within 500 m) to a major road or a freeway to be
chronically exposed to elevated concentrations. Additionally,
daily behavior brings most people close to this source, with
the average US citizen over 15 years of age spending 55
minutes each day traveling in motor vehicles.21 However,
despite the consistent epidemiological findings, these studies
have yet to elucidate which of the many pollutants or other
associated risks (ie, noise) produced by traffic are responsible
for the increase in risk for CVD. Until the most harmful
agents are identified, the only practical manner to potentially
reduce health consequences would be to reduce overall traffic
and related emissions and to configure cities and lifestyles
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such that there is greater separation between the people and
the source, so that we could spend less time in traffic (a major
source of personal exposures in our society). There are also a
myriad of other important pollutant sources of known toxic
pollutants that have been implicated in health-effect studies
(eg, power generation, industrial sources, steel mills, and
wood smoke). A better understanding of the factors that
influence population exposure to these sources, of how their
emissions and mixtures of different sources affect health, and
about the factors that make individuals more susceptible will
aid in the development of more effective environmental
health policies.
Determinants of Air Pollution Exposure
Many aspects of air pollution play a role in the characteristics
of population- and individual-level exposures. Pollutants vary
on multiple time scales, with emission rates, weather patterns,
and diurnal/seasonal cycles in solar radiation and temperature
having the greatest impact on concentrations. The temporal
behavior of a pollutant is also governed by its formation rate
and the length of time it remains in the atmosphere. As such,
the concentrations of many air pollutants tend to co-vary. For
example, NOx and CO are emitted during combustion, as are
some particle constituents (eg, elemental carbon) and VOCs,
and thus, their concentrations peak during rush hour. On the
other hand, O3 and other photochemical oxidants, including
secondary PM2.5 and secondary VOCs, peak in the afternoon,
particularly given certain meteorologic conditions (eg, more
sunshine). Among the common air pollutants, O3 and PM2.5
have the longest atmospheric lifetime and thus can build up
over multiple days and spread, by the prevailing winds, over
large geographic regions. This can lead to similarities in their
temporal and spatial patterns over broad regions and to
greater numbers of people being exposed to similar levels,
thus lessening interindividual variability in exposure.
Periods of suppressed horizontal and vertical mixing in the
lower atmosphere lead to the buildup of multiple pollutants.
These situations are most common under slow-moving or
stationary high-pressure systems, which bring light winds, a
stable atmosphere, and more sunshine. The frequency and
seasonality of these meteorologic conditions and how they
affect concentrations vary geographically, which leads to
differences in the characteristics of pollution episodes from
the western to the eastern United States, as well as within
these regions.
The commonality of meteorology and emission sources
leads to covariation in pollutant concentrations on multiple
temporal and spatial scales, which makes it more challenging
for epidemiological studies to identify the health effects of
individual pollutants and the effects of copollutants or mix-
tures. Studies that depend on daily counts of mortality or
morbidity events have difficulties separating the effects of the
different pollutants in the urban mix. Even prospective panel
studies measuring specific end points on a subdaily time scale
are hindered by pollutant covariation. Some of these chal-
lenges could potentially be addressed by undertaking studies
covering multiple geographic locations with differences in
the structure of pollutant covariation due to different meteo-
rology and source mixes. Indeed, this has been done, at least
in part, by several existing multicity studies. Consistency in
the findings in individual studies conducted in different cities
also helps isolate the pollutants that may be more responsible
for the health effects. The consistent positive findings with
certain pollutants (eg, PM mass concentration) have helped
strengthen the evidence regarding PM10 and PM2.5 effects,
but regardless of location, there remains the strong underlying
commonality of fossil fuel combustion for many pollutants.
A final issue to consider is the cardiovascular health effects
of exposures that occur at the personal level because of the
different microenvironments or activities an individual expe-
riences (eg, time in traffic, indoor sources, secondhand
tobacco smoke, occupational exposure, and degree of indoor
penetration of ambient PM into homes) versus the effects of
exposures from less variable urban- to regional-scale ambient
concentrations (ie, background pollution that most individu-
als encounter more uniformly). Personal monitoring demon-
strates substantial variations among individual pollution ex-
posures or characteristics among those living within the same
metropolitan area and even the same neighborhood.22,23
However, the differing additive, synergistic, and/or con-
founding effects on cardiovascular health of these 2 contrast-
ing components of a person’s overall exposure have not been
well described. For the most part, the magnitude of the
findings reported by the major epidemiological studies (see
next section) are indicative of the effects of the urban- to
regional-scale ambient concentrations. Actual exposures to
all pollutants also vary at the personal level. The cardiovas-
cular health importance of these individual-level variations
(above and beyond the effect of urban/regional levels) re-
mains largely unknown, in part because it has been difficult to
quantify. The degree to which measurement of personal expo-
sures or more precise exposure assessment (eg, use of geo-
graphic information systems, land-use regression models,
spatial-temporal models, and adjustments for indoor penetration)
can reduce the effects of exposure misclassification in epidemi-
ological studies also remains to be fully elucidated.24–26
Epidemiological Studies of Air Pollution
Epidemiological studies of air pollution have examined the
health effects of exposures observed in real-world settings at
ambient levels. Associations between relevant health end
points and measures of air pollution are evaluated while
attempting to control for effects of other pertinent factors (eg,
patient and environmental characteristics). Despite substan-
tial study and statistical improvements and the relative
consistency of results, some potential for residual confound-
ing of variables and publication bias27 of positive studies are
limitations to acknowledge. Probably the most relevant,
well-defined, and extensively studied health end points in-
clude mortality (all-cause and cause-specific), hospitaliza-
tions, and clinical cardiovascular events. This section reviews
the results of the epidemiological research with a focus on
new studies since the first AHA statement was published,1 as
well as on the cardiovascular health implications. In sum,
numerous studies of varied design have been published in the
interim that significantly add to the overall weight of evi-
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dence that exposure to air pollutants at present-day levels
contributes to cardiovascular morbidity and mortality.
Mortality and Air Pollution
Time-Series and Related Studies
Time-series and case-crossover studies explore associations
between short-term changes in air pollution and daily changes
in death counts. The sum of current evidence supports the
findings of an earlier review28 that demonstrated that short-
term elevations in daily PM levels lead to a greater absolute
risk for CVD-related mortality than for all other causes. Even
if similar acute RR elevations (1.01) are estimated between
cardiovascular and pulmonary mortality, CVDs account for
69% of the increase in absolute mortality rates compared with
28% for pulmonary diseases attributable to short-term PM
exposure. Recently, more rigorous modeling techniques have
been used in attempts to better estimate pollution-mortality
associations while controlling for other time-dependent con-
founding covariables.29,30 There have been well over 100
published daily time-series studies reporting small but statis-
tically significant PM-mortality associations that have been
the subject of quantitative reviews or meta-analyses.3,27,31–33
Table 2 summarizes recent multicity analyses and studies
published since 2004.
To address concerns about city selection bias, publication
bias, and influences of copollutants, several large, multicity,
daily time-series studies have been conducted worldwide.
One of the largest was the National Morbidity, Mortality,
and Air Pollution Study (NMMAPS). Published reports
from this study included as few as 20 US cities,44,45 as
many as 100 cities,46,47 and more recently, data for
hundreds of counties (Table 2).48 The observed relation-
ship between PM exposure and excess mortality remained
independent of several gaseous copollutants (NO2, CO, or
SO2). Recent analyses suggest that O3 may also indepen-
dently contribute to cardiopulmonary mortality risk49,50;
however, coexposures to secondary particle pollutants may
be responsible in part for this latter association.51
Several studies have also been conducted outside the
United States, including the Air Pollution and Health: A
European Approach (APHEA and APHEA-2) projects,
which examined daily PM-related mortality effects in
multiple cities.36,52 PM air pollution was significantly
associated with daily mortality counts for all-cause, car-
diovascular, and respiratory mortality (Table 2). Further
analyses of the European data suggest that CVD deaths are
also associated with exposure to NO253 and CO.54 A few
new time-series studies have also confirmed similar in-
creases in cardiovascular mortality related to short-term
PM exposure in China55–57 and Bangkok, Thailand.42
Additional multicity studies have been conducted world-
wide with analyses of CVD deaths (Table 2).38 – 42,58 – 60
Finally, in a recent analysis that included several Asian
Table 2. Comparison of Pooled Estimated of Percent Increase (and 95% CI or Posterior Interval or t Value) in RR of Mortality
Estimated Across Meta-Analyses and Multicity Studies of Daily Changes in Exposure
Primary Source Exposure Increment
Percent Increases in Mortality (95% CI)
All-Cause Cardiovascular Respiratory
Meta-estimate with and without
adjustment for publication bias
Anderson et al27 2005 20 g/m3 PM10 1.0 (0.8–1.2)
1.2 (1.0–1.4)
… …
Meta-estimates from COMEAP
report to the UK Department of
Health on CVD and air pollution
COMEAP31 2006 20 g/m3 PM10
10 g/m3 PM2.5
…
…
1.8 (1.4–2.4)
1.4 (0.7–2.2)
…
…
NMMAPS, 20 to 100 US cities Dominici et al34 2003 20 g/m3 PM10 0.4 (0.2–0.8) 0.6 (0.3–1.0)* …
APHEA-2, 15 to 29 European cities Katsouyanni et al35 2003 20 g/m3 PM10 1.2 (0.8–1.4) 1.5 (0.9–2.1) 1.2 (0.4–1.9)
Analitis et al36 2006
US, 6 cities Klemm and Mason37 2003 10 g/m3 PM2.5 1.2 (0.8–1.6) 1.3 (0.3–2.4)† 0.6 (2.9, 4.2)‡
US, 27 cities, case-crossover Franklin et al38 2007 10 g/m3 PM2.5 1.2 (0.3–2.1) 0.9 (.1, 2.0) 1.8 (0.2, 3.4)
California, 9 cities Ostro et al39 2006 10 g/m3 PM2.5 0.6 (0.2–1.0) 0.6 (0.0, 1.1) 2.2 (0.6, 3.9)
France, 9 cities Le Tertre et al40 2002 20 g/m3 BS 1.2 (0.5–1.8)§ 1.2 (0.2–2.2)§ 1.1 (1.4, 3.2)§
Japan, 13 cities, age 65 y Omori et al41 2003 20 g/m3 SPM 1.0 (0.8–1.3) 1.1 (0.7–1.5) 1.4 (0.9–2.1)
Asia, 4 cities Wong et al42 2008 10 g/m3 PM10 0.55 (0.26–0.85) 0.59 (0.22–0.93) 0.62 (0.16–1.04)
US, 112 cities Zanobetti et al43 2009 10 g/m3 PM2.5 0.98 (0.75–1.22) 0.85 (0.46–1.24) 1.68 (1.04–2.33)
10 g/m3 PM10–2.5 0.46 (0.21–0.71) 0.32 (0.00–0.64) 1.16 (0.43–1.89)
10 g/m3 PM2.5¶ 0.77 (0.43–1.12) 0.61 (0.05–1.17) 1.63 (0.69–2.59)
10 g/m3 PM10–2.5¶ 0.47 (0.21–0.73) 0.29 (0.04, 0.61) 1.14 (0.043–1.85)
CI indicates confidence interval or posterior interval.
*Cardiovascular and respiratory deaths combined.
†Ischemic heart disease deaths.
‡Chronic obstructive pulmonary disease deaths.
§Includes general additive model–based analyses with potentially inadequate convergence.
Results for PM10–2.5 are from 47 cities.
¶Results of 2 pollutant models controlling for alternate PM size in 47 cities.
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cities, SO2, NO2, O3, and PM10 were all associated with
excess cardiovascular mortality.42
In an attempt to evaluate the coherence of multicity studies
across continents, the Air Pollution and Health: A Combined
European and North American Approach (APHENA) study
analyzed data from the APHEA, NMMAPS, and Canadian
studies.61 The combined effect on all-cause mortality ranged
from 0.2% to 0.6% for a 10-g/m3 elevation in daily ambient
PM10, with the largest effects observed in Canada. Among
individuals older than 75 years, the effects were greater for
cardiovascular mortality than for overall and pulmonary
mortality (0.47% to 1.30%). Older age (75 years) and
higher rates of unemployment were related to greater PM
mortality risks in both continents. Higher NO2 levels were
associated with larger PM10 effects on mortality, particularly
in Europe. Finally, there appeared to be no lower-limit
threshold below which PM10 was not associated with excess
mortality across all regions.
Evidence Summary
The overall evidence from time-series analyses conducted
worldwide since publication of the first AHA statement1
confirms the existence of a small, yet consistent association
between increased mortality and short-term elevations in
PM10 and PM2.5 approximately equal to a 0.4% to 1.0%
increase in daily mortality (and cardiovascular death specif-
ically) due to a 10-g/m3 elevation in PM2.5 during the
preceding 1 to 5 days (Table 2).
Cohort and Related Studies
Although short-term changes in PM concentrations have
deleterious health effects, longer-term exposures may have
a more pertinent clinical health effect on cardiovascular
morbidity and mortality given that individuals are typically
exposed to higher air pollution levels over extended
periods of time. An additional source of exposure variabil-
ity that has been exploited in epidemiological studies is
spatial variability, which includes differences in average
ambient concentrations over extended periods of time
across metropolitan areas or across smaller communities
within local areas. Recent emphasis has been on prospec-
tive cohort studies that control for individual differences in
multiple confounding variables and cardiovascular risk
factors. A summary of these studies is presented in Table
3 and Figure 1. These cohort studies generally demonstrate
larger overall mortality effects than the results of time-
series analyses.
Harvard Six Cities and ACS Studies
Two landmark cohort-based mortality studies, the Harvard
Six Cities62 and the ACS studies,66 were reported in the
mid 1990s and were discussed previously.1 In both, PM2.5
and sulfate particulate pollution were associated with
increases in all-cause and cardiopulmonary disease (Table
3). In addition, intensive independent reanalyses63 corrob-
orated the original findings of both studies and resulted in
innovative methodological contributions that demonstrated
the robustness of the results to alternative modeling
approaches. In both the Harvard Six Cities62,64 and the
ACS67 studies, PM air pollution–related mortality was
substantially higher for cardiovascular- than for pulmo-
nary-related causes.
Since 2004, there have been further analyses of both
studies. Laden et al64 extended the mortality follow-up of
the Harvard Six Cities cohort for an additional 8 years.
PM2.5 associations, similar to those found in the original
analysis, were observed for all-cause and CVD mortality
(Table 3). Furthermore, reductions in PM2.5 concentrations
for the extended follow-up period were associated with
reduced mortality risk. Further analysis suggested that the
health effects of changes in exposure were seen primarily
within 2 years.84 In addition to confirming the earlier
mortality relationship, the recent observations suggest that
the adverse health effects mediated by longer-term PM air
pollution exposure can be estimated reasonably accurately
by the previous few years of particle levels.
Extended analyses of the ACS cohort that emphasize
efforts to control for the effects of other covariates and risk
factors have corroborated the previously reported mortality
associations with particulate and sulfur oxide pollution.68
Elevated mortality risks were most strongly associated with
PM2.5. Coarse particles (PM10–2.5) and gaseous pollutants,
except for SO2, were generally not significantly related to
mortality. In another extended analysis,67 the death certificate
classifications of underlying causes of death due to PM2.5
exposures were observed to be principally ischemic heart
disease, arrhythmias, heart failure, and cardiac arrest. Finally,
recent additional analyses attempted to control for the fact
that variations in exposure to air pollution across cities or
within cities may correlate with socioeconomic or demo-
graphic gradients that influence health and susceptibility to
environmental exposures.85,86 When controlled for individual
risk factor data, the mortality associations for intrametropoli-
tan PM2.5 concentration differences within the Los Angeles,
Calif, area were generally larger than those observed in the
full cohort across metropolitan areas.69 However, the results
were somewhat sensitive to the inclusion of zip code–level
ecological variables, which suggests potential contextual
neighborhood confounding. Krewski et al70 subsequently
observed that full adjustments for multiple ecological covari-
ates did not reduce the estimated PM2.5-related mortality
effect. The association for ischemic heart disease mortality in
particular was highly robust across various study areas and
modeling strategies and after controlling for both individual
and ecological covariates.
An additional recent analysis of the ACS cohort evaluated
the health effects of ozone compared with PM2.5.87 The
findings reconfirmed the independent cardiovascular mortal-
ity increase related to fine-particle exposure. However, after
adjustment for PM2.5, ozone was associated solely with an
elevated risk of death due to respiratory causes; there was no
independent risk of ozone exposure on CVD-related mortal-
ity. This suggests that the positive findings reported in
NMMAPS50 regarding cardiopulmonary mortality and short-
term ozone exposure could be explained at least in part by the
enhanced risk of mortality due to lung disease categories.
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Table 3. Summary of Cohort Study Results
Study
Size of
Cohort
(000s)
Follow-Up
Period
Covariates
Controlled for
Percent Increases in Mortality (95% CI) Associated With 10 g/m3 PM2.5
(or Other When Indicated)
All-Cause Cardiopulmonary Cardiovascular
Ischemic Heart
Disease
Harvard Six Cities, original
(Dockery et al62 1993)
8 1974–1991 Individual
(smokingothers)
13 (4.2–23) 18 (6.0–32) … …
Harvard Six-Cities, HEI
reanalysis, Krewski et al63
2004
8 1974–1991 Individual
(smokingothers)
14 (5.4–23) 19 (6.5–33) … …
Harvard Six-Cities, extended,
Laden et al64 2006
8 1974–1998 Individual
(smokingothers)
16 (7–26) … 28 (13–44) …
Six-Cities Medicare cohort,
Eftim et al65 2008
340 2000–2002 Individual (age,
sex)
21 (15–27) … … …
ACS, Original, Pope et al66
1995
500 1982–1989 Individual
(smokingothers)
6.6 (3.5–9.8) 12 (6.7–17) … …
ACS, HEI reanalysis, Krewski
et al63 2004
500 1982–1989 Individual
(smokingothers)
ecological
7.0 (3.9 10) 12 (7.4–17) 13 (8.1–18) …
ACS, extended I, Pope et
al67,68 2002, 2004
500 1982–1998 Individual
(smokingothers)
6.2 (1.6–11) 9.3 (3.3–16) 12 (8–15) 18 (14–23)
ACS, intrametro Los Angeles,
Jerrett et al69 2005
23 1982–2000 Individual
(smokingothers)
ecological
17 (5–30) 12 (3–30) … 39 (12–73)
ACS, extended II, Krewski
et al70 2009
500 1982–2000 Individual
(smokingothers)
ecological
5.6 (3.5–7.8) 13 (9.5–16) … 24 (20–29)
ACS, Medicare cohort,
Eftim et al65 2008
7333 2000–2002 Individual (age,
sex)ecological
COPD
11 (9–13) … … …
US Medicare cohort,
east/central/west, Zeger
et al71 2008
13 200 2000–2005 Individual (age,
sex)ecological
COPD
6.8 (4.9–8.7),*
13 (9.5–17)
1.1 (3 to 0.8)
… … …
Women’s Health Initiative,
Miller et al72 2007
66 1994–2002 Individual
(smokingothers)
… … 76 (25–147),
24 (9–41)†
…
Nurses’ Health Study,
Puett et al73 2008
66 1992–2002 Individual
(smokingothers)
ecological
7.0 (3.0 to 18)‡ … 30 (0–71)‡ …
AHSMOG, males only,
McDonnell et al74 2000
4 1977–1992 Individual
(smokingothers)
8.5 (2.3 to 21) 23 (3 to 55) … …
AHSMOG, females only,
Chen et al75 2005
4 1977–2000 Individual
(smokingothers)
… … 42 (6–90) …
VA hypertensive male I
study, Lipfert et al76 2006
42 1989–1996 Individual
(smokingothers)
ecological
15 (5–26)§ … … …
VA hypertensive male II
study, Lipfert et al77 2006
30 1997–2001 Individual
(smokingothers)
ecological
6 (6 to 22) … … …
11 CA county, elderly,
Enstrom78 2005
36 1973–2002 Individual
(smokingothers)
ecological
4 (1–7),
1 (0.6 to 2.6)
… … …
French PAARC, Filleul
et al79 2005
14 1974–2000 Individual
(smokingothers)
7 (3–10)‡ 5 (2 to 12)‡ … …
German women, Gehring
et al80 2006
5 1980s,
1990s–2003
Individual
smoking and
socioeconomic
status
12 (8 to 38) 52 (9–115) … …
(Continued)
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Additional Cohort Studies
Several additional cohort studies have been published in the
past few years (Table 3). Eftim and colleagues65 studied 2
very large “cohorts” of US Medicare participants who lived
in locations included in the Harvard Six Cities and ACS
studies. Effects of PM2.5 exposure on mortality for the period
2000 to 2002 were estimated after controlling for multiple
factors, although not at the individual patient level. For
all-cause mortality, the PM2.5-mortality associations were
larger than those observed in the Harvard Six Cities or ACS
cohorts. In an additional analysis of 13.2 million US Medi-
care participants for the time period 2000 to 2005,71 PM2.5-
mortality associations were shown to be similar to those
observed in the Harvard Six Cities and ACS studies in the
East and Central regions of the United States (and when the
data were pooled for the entire United States). However,
PM2.5 was not associated with mortality in the Western
United States or for the oldest age group (85 years old).
These findings generally corroborate the earlier cohort stud-
ies and add evidence that aspects of exposure (PM sources or
composition) and patient susceptibility might play important
roles in determining the health risks.
In a cohort of postmenopausal women without prior CVD
from the Women’s Health Initiative Observational Study,72
an association between longer-term PM2.5 exposure (median
follow-up of 6 years) and cardiovascular events (primary end
point) was observed. After adjustment for age and other risk
factors, an incremental difference of 10 g/m3 PM2.5 was
associated with a 24% (95% confidence interval [CI]9% to
41%) increase in all first cardiovascular events (fatal and
nonfatal, with a total of 1816 cases). Notably, an incremental
difference of 10 g/m3 PM2.5 was also associated with a large
76% (95% CI 25% to 147%) increase in fatal cardiovascular
events, based on 261 deaths. The risks for both coronary heart
disease and strokes were found to be similarly elevated.
Interestingly, within-city PM2.5 gradients appeared to have
larger cardiovascular effects than those between cities, al-
though this difference was not statistically significant. Fi-
nally, overweight women (body mass index 24.8 kg/m2)
were at relatively greater cardiovascular risk due to particu-
late air pollution than leaner women. Noteworthy aspects of
this study were improved assessment of the end points by
medical record review (rather than by death certificate) and
long-term particle exposure estimation. The control for
individual-level confounding variables was also superior to
that of previous cohort studies.
In another cohort of women, a subset of the Nurses’ Health
Study from the northeastern United States,73 an increase of 10
g/m3 modeled estimates of PM10 exposures was associated
with an approximately 7% to 16% increased risk of all-cause
mortality and a 30% to 40% increase in fatal coronary heart
disease, depending on the level of adjustment for covariates.
This study found that the strongest health risks for all-cause
and cardiovascular mortality were seen in association with
the average PM10 exposure during the previous 24 months
before death. Similar to the findings of the Women’s Health
Initiative, the cardiovascular mortality risk estimates were
larger than those of previous cohort studies. In addition,
obese women (body mass index 30 kg/m2) were at greater
relative risk, and the increases in mortality (all-cause and
cardiovascular) were larger than the effects on nonfatal
events. The results were also in accordance with the latest
Harvard Six Cities analyses64 that show that exposure over
the most recent preceding 1 to 2 years can accurately estimate
the majority of the health risks due to longer-term PM air
pollution exposures.
The pollution-mortality association has also been assessed
in several other cohort studies in the United States and
Europe (Table 3).76–83 In a recent analysis of the Adventist
Health Study of Smog (AHSMOG) cohort with a much
Table 3. Continued
Study
Size of
Cohort
(000s)
Follow-Up
Period
Covariates
Controlled for
Percent Increases in Mortality (95% CI) Associated With 10 g/m3 PM2.5
(or Other When Indicated)
All-Cause Cardiopulmonary Cardiovascular
Ischemic Heart
Disease
Oslo, Norway, intrametro,
Naess et al81 2007
144 1992–1998 Individual age,
occupational
class, education
… … 10 (5–16),¶
14 (6–21),
5 (1–8),
3 (0–5)
…
Dutch cohort, Beelen
et al82 2008
121 1987–1996 Individual
(smokingothers)
ecological
6 (3 to 16) … 4 (10 to 21) …
Great Britain, Elliott
et al83 2007
660 1966–1998 Socioeconomic
status
1.3 (1.0–1.6)‡# 1.7 (1.3–2.2)‡# 1.2 (0.7–1.7)‡#
HEI indicates Health Effects Institute; VA, Veterans Affairs; COPD, chronic obstructive pulmonary disease; and CA, California.
*Three estimates are for the East, Central, and West regions of the United States, respectively.
†Any cardiovascular event.
‡Associated with 10 g/m3 British Smoke (BS) or PM10.
§Estimates from the single-pollutant model. Effect estimates were smaller and statistically insignificant in analyses restricted to counties with nitrogen dioxide data.
County-level traffic density was a strong predictor of survival, and stronger than PM2.5 when included with PM2.5 in joint regressions.
Two estimates are for the follow-up period 1973–1982 and the follow-up period 1983–2002, respectively.
¶Four estimates are for men 51–70 y old, women 51–70 y old, men 71–90 y old, and women 71–90 y old, respectively.
#Using last 0- to 4-year exposure window.
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longer follow-up than the original studies,74,88 fatal coronary
heart disease was significantly associated with PM2.5 among
females but not males.75 These observations along with the
remarkably robust health effects in the Women’s Health
Initiative Observational Study and Nurses’ Health Study
suggest that women may be at special risk from PM exposure.
The overall cohort study evidence demonstrates that a 10-
g/m3 increase in PM2.5 exposure is in general positively
associated with excess mortality, largely driven by increases
in cardiopulmonary or cardiovascular deaths (Figure 1).
Independent results from the Women’s Health Initiative
Study,72 the US Medicare cohorts,71 the German women
cohort,80 and the intracity Oslo (Norway) study81 contribute
substantially to this evidence. Although the Dutch cohort,82
AHSMOG,74,75 French PAARC (Pollution Atmosphe´rique et
Affections Respiratoires Chroniques [air pollution and
chronic respiratory diseases]),79 Veterans Affairs hypertensive
male study,77 and 11 CA county78 studies observed increased
mortality risks associated with higher PM2.5 exposure that were
statistically significant in some analyses, the observed health
risks were less robust. A finding that is somewhat consistent
across the Veterans Affairs hypertensive male study,77 11 CA
county,78 Oslo,81 and US Medicare cohorts71 is that the PM2.5-
mortality effect estimates tend to decline with longer periods of
follow up or in a substantially older cohort. These studies also
often observed elevated mortality risks according to alternative
indicators of air pollution exposure, especially metrics of traffic-
related exposure.
Evidence Summary
The overall evidence from the cohort studies demonstrates on
average an approximate 10% increase in all-cause mortality
per 10-g/m3 elevation in long-term average PM2.5 exposure.
The mortality risk specifically related to CVD appears to be
elevated to a similar (or perhaps even greater) extent, ranging
from 3% to 76% (Table 3). This broader estimated range in
risk compared with the short-term effects observed in time
series is due to several recent cohort studies72,73 that demon-
strated larger cardiovascular mortality risks (eg, 30%) than
in earlier cohort observations. This may reflect superior
aspects of these studies that allowed for a better character-
ization of the cardiovascular risk of long-term exposure, the
fact that these cohorts consisted of only women, or other
unclear reasons. Compared with cardiovascular mortality,
there is less existing evidence to support an increase in the
risk for nonfatal cardiovascular events related to PM2.5
exposure among the existing cohort studies, because many of
them did not specifically investigate nonfatal outcomes, and
several of the more recent studies reported nonsignificant
relationships.72,73
Natural Experiment and Intervention Studies
Several studies have shown improvements in health outcomes
in association with exposures using well-defined natural
experiments or interventions, such as abrupt reductions in air
pollution89–91 or changes over a longer period of time.64,92
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Figure 1. Risk estimates provided by several cohort studies per increment of 10 g/m3 in PM2.5 or PM10. CPD indicates cardiopulmo-
nary disease; IHD, ischemic heart disease.
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Small but statistically significant drops in mortality were
associated with an 81⁄2-month copper smelter strike that
resulted in sharp reductions in sulfate PM and related air
pollutants across 4 Southwest states, even after controlling for
other factors.93 Data from US Medicare enrollment files were
used to estimate the association between changes in monthly
mortality rates for US counties and average PM2.5 concentra-
tions for the previous 12 months.94 PM2.5-mortality associa-
tions were observed at the national scale but not the local
scale, which raises concerns about possible statistical con-
founding due to unmeasured individual and ecological vari-
ables as a cause for any positive findings in this study.
However, a recent large study found that reductions in PM air
pollution exposure on a local scale (across US counties) over
a 2-decade period (1980s and 1990s) were associated with
increased life expectancy even after controlling for changes
in socioeconomic, demographic, and proxy smoking vari-
ables.95 Indeed, a decrease of 10 g/m3 in the long-term
PM2.5 concentration was related to an increase in mean life
expectancy of 0.610.20 years.
Hospitalization Rates
There are many daily time-series or case-crossover studies
that have evaluated associations between cardiovascular hos-
pitalizations and short-term changes in air pollution. Because
of the great number of publications, all studies (particularly
those focusing on nonparticulate air pollutants) cannot be
discussed individually. Nevertheless, Table 4 presents a
comparison of pooled estimates of percent increase in RR of
hospital admission for general cardiac conditions across a
previous meta-analysis of 51 published estimates (COMEAP
[Committee on the Medical Effects of Air Pollutants]) and
results from many selected multicity studies published after
2004. Several studies before 2004 are included in Table 4
only to demonstrate the consistency of effect.
Because of its comparatively large size and importance, the
results of a recent analysis of Medicare files in 204 US urban
counties with 11.5 million individuals older than 65 years
merit discussion. Daily changes in PM2.5 levels were associ-
ated with a variety of cardiovascular hospital admission
subtypes.103 A 10-g/m3 increase in PM2.5 exposure was
related to increases in hospitalizations for cerebrovascular
disease by 0.81% (95% CI 0.3% to 1.32%), peripheral
vascular disease by 0.86% (95% CI 0.06% to 1.79%),
ischemic heart disease by 0.44% (95% CI 0.02% to 0.86%),
arrhythmias by 0.57% (95% CI 0.01% to 1.15%), and heart
failure by 1.28 (95% CI 0.78% to 1.78%). The most rapid
effects, which occurred largely on the same day of PM2.5
elevation, were seen for cerebrovascular, arrhythmia, and
heart failure admissions. Ischemic heart disease events tended
to increase to a greater extent 2 days after exposures. A
consistent finding was that the cardiovascular effects of
pollution were much stronger in the Northeast than in other
regions. In fact, there were few significant associations in
Western US regions. It was speculated that these differences
reflected variations in particle composition (eg, greater sul-
fate in the East and nitrate components in the West) and
pollution sources (eg, power generation in the East and
transportation sources in the West). In a follow-up analysis by
Peng et al,104 PM10–2.5 levels were not statistically associated
with cardiovascular hospitalizations after adjustment for
PM2.5. This suggests that the smaller particles (ie, PM2.5) are
principally responsible for the cardiovascular hospitalizations
attributed in prior studies to the combination of both fine and
coarse particles (ie, PM10). Given the differences between the
size fractions, the results imply that particles and their
components derived from combustion sources (ie, PM2.5) are
more harmful to the cardiovascular system than larger coarse
particles. Finally, there is some evidence that gaseous pollut-
ants may also instigate hospitalizations. Hospital admissions
for cardiovascular causes, particularly ischemic heart disease,
were found to rise in relation to the previous-day and
same-day level of SO2, even after adjustment for PM10
levels.105
Table 4. Comparison of Pooled Estimated of Percent Increase in Risk of Hospital Admission for CVD
Estimated Across Meta-Analyses and Multicity Studies of Daily Changes in Exposure
Primary Source Exposure Increment % Increase (95% CI)
Cardiac admissions, meta-analysis of 51 estimates COMEAP31 2006 20 g/m3 PM10 1.8 (1.4–1.2)
Cardiac admissions, 8 US cities Schwartz96 1999 20 g/m3 PM10 2.0 (1.5–2.5)
Cardiac admissions, 10 US cities Zanobetti et al97 2000 20 g/m3 PM10 2.6 (2.0–3.0)
Cardiac admissions, 14 US cities Samet et al98 2000 20 g/m3 PM10 2.0 (1.5–2.5)
Schwartz et al99 2003
Cardiac admissions, 8 European cities Le Tertre et al40 2002 20 g/m3 PM10 1.4 (0.8–2.0)
Cardiovascular admissions, 14 Spanish cities Ballester et al100 2006 20 g/m3 PM10 1.8 (7–3.0)
Cardiovascular admission, 8 French cities Larrieu et al101 2007 20 g/m3 PM10 1.6 (0.4–3.0)
Cardiovascular admissions, 202 US counties Bell et al102 2008 20 g/m3 PM10 0.8 (0.6–1.0)
Medicare national claims history files Dominici et al103 2006 10 g/m3 PM2.5
Ischemic heart disease, 0.44 (0.02–0.86)
Cerebrovascular disease 0.81 (0.30–1.32)
Heart failure 1.28 (0.78–1.78)
Heart rhythm 0.57 (0.01 to 1.15)
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Evidence Summary
Excess cardiovascular mortality and increased rates of hos-
pitalizations are similarly associated with day-to-day changes
in PM air pollution (Tables 2 and 4). However, significant
differences between geographic regions in the risk relation-
ships have been observed, and more investigation is required
to explain this heterogeneity.
Specific Cardiovascular Events/Conditions
Ischemic Heart Disease
Among the cohort studies that provided relevant results, the
ACS study found a relationship between increased risk for
ischemic heart disease death and long-term exposure to
elevated PM2.5 levels (Table 3).67,69,106 Indeed, ischemic
cardiac events accounted for the largest relative (RR 1.18,
95% CI 1.14 to 1.23) and absolute risk for mortality per
10-g/m3 elevation in PM2.5.67 A survival analysis of US
Medicare data for 196 000 survivors of acute MI in 21 cities
showed the risk of an adverse post-MI outcome (death,
subsequent MI, or first admission for congestive heart failure)
was increased with higher exposure to PM10.107 Data from the
Worcester Heart Attack study also found that long-term
exposure to traffic-related air pollution was associated with
significantly increased risk of acute MI.108 However, in the
Women’s Health Initiative72 and the Nurses’ Health Study,73
only disease categories that included fatal coronary events,
but not nonfatal MI alone, were statistically elevated in
relation to PM2.5. The effect size for cardiovascular mortality
was much larger and much more statistically robust than for
nonfatal events such as MI in both studies.
Various time-series and case-crossover studies have also
reported increased ischemic heart disease hospital admissions
associated with short-term elevated concentrations of inhal-
able and/or fine PM air pollution.31,40,103 In the US Medicare
study, a reduction of PM2.5 by 10 g/m3 was estimated to
reduce ischemic heart disease admissions in 204 counties by
1523 (95% posterior interval 69 to 2976) cases per year.103
Several studies have also found positive associations between
elevated PM or traffic exposures over a period as brief as a
few hours109–111 or a few days and an elevated risk for MI
(Table 5).13,110,112–115 In general, acute increases in risk for
ischemic heart disease events have been observed consis-
tently, even as rapidly as 1 to 2 hours after exposure to
elevated PM, in case-crossover analyses.109–111 Other studies
have reported an increased risk for MI shortly after exposure
to traffic. Peters et al111 reported in 691 subjects in Augsburg,
Germany, a strong association (odds ratio 2.92, 95% CI 2.22
to 3.83) between onset of MI and traffic exposure within the
past hour, although whether this was a result of the air
pollution or a combination of other factors (eg, noise and
stress) is not certain. Additional analyses did not report an
association between recent UFP exposures and MI onset;
however, the levels of PM2.5 and several gaseous pollutants 2
days earlier were related to MI risk.116 The lack of relation-
ship between MI and UFPs may be due to the fact that the
levels were measured regionally and remote from the local-
ized source and may therefore reflect exposure misclassifica-
tion. Finally, in the only study in which participating subjects
had coronary angiograms performed previously, ischemic
cardiac events were found to occur in relation to PM air
pollution exposure solely among individuals with obstructive
coronary atherosclerosis in at least 1 vessel.13 This finding
suggests the importance of patient susceptibility (eg, the
presence of preexisting coronary artery disease) for PM to
trigger an acute ischemic event within hours to days after
exposure.
Heart Failure
In the ACS cohort study, it appeared that deaths due to
arrhythmias, heart failure, and cardiac arrest (RR 1.13, 95%
CI 1.05 to 1.21 per 10 g/m3) were also associated with
Table 5. Comparisons of Estimated Percent Increase in Risk of Ischemic Heart Disease Events due to Concurrent or Recent Daily
PM Exposure
Event/Study Area Primary Source Exposure Increment % Increase (95% CI)
MI events–Boston, Mass Peters et al110 2001 10 g/m3 PM2.5 20 (5.4–37)
MI, 1st hospitalization–Rome, Italy D’Ippoliti et al112 2003 30 g/m3 TSP 7.1 (1.2–13.1)
MI, emergency hospitalizations–21 US cities Zanobetti and Schwartz113 2005 20 g/m3 PM10 1.3 (0.2–2.4)
Hospital readmissions for MI, angina, dysrhythmia,
or heart failure of MI survivors–5 European cities
Von Klot et al114 2005 20 g/m3 PM10 4.2 (0.8–8.0)
MI events–Seattle, Wash Sullivan et al115 2005 10 g/m3 PM2.5 4.0 (4.0–14.5)
MI and unstable angina events–Wasatch Front, Utah Pope et al13 2006 10 g/m3 PM2.5 4.8 (1.0–6.6)
Tokyo metropolitan area Murakami et al109 2006 TSP 300 g/m3 for 1 h vs
reference periods 99 g/m3
40 (0–97)*
Nonfatal MI, Augsburg, Germany Peters et al111 2004 Exposure to traffic 1 h before MI
(note: not PM but self-reported
traffic exposure)
292 (222–383)
Nonfatal MI, Augsburg, Germany Peters et al116 2005 Ambient UFP, PM2.5, and PM10
levels
No association with UFP or PM2.5
on same day. Positive associations
with PM2.5 levels on
2 days prior
TSP indicates total suspended particulate matter.
*Adjusted rate ratio for MI deaths.
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prolonged exposure to PM2.5, although not as strongly as
ischemic heart disease mortality,67 although potential mortal-
ity misclassification on death certificates makes the actual
cause of death not entirely certain in all circumstances. Heart
failure rates or mortality associations were not reported in the
other cohort studies.
Daily hospitalizations for heart failure have also been
associated with short-term changes in PM exposure.31 Heart
failure associations with PM were observed in a large daily
time-series analysis of PM2.5 and cardiovascular and re-
spiratory hospitalizations by use of a national database
constructed from US Medicare files.103 A 10-g/m3 in-
crease in concurrent-day PM2.5 was associated with a
1.28% (95% CI 0.78% to 1.78%) increase in heart failure
admissions, the single largest cause for hospitalization in
this cohort. A reduction of PM2.5 by 10 g/m3 was
estimated to reduce heart failure admissions in 204 coun-
ties by 3156 (95% posterior interval 1923 to 4389) cases
per year.103 Another analysis in Medicare recipients in 7
US cities found a 10-g/m3 increase in concurrent-day
PM10 was associated with a 0.72% (95% CI 0.35% to
1.10%) increase in heart failure admissions.117 Traffic-
related air pollution has also been shown to be signifi-
cantly associated with increased mortality risk after acute
heart failure.118 Finally, a study from Utah’s Wasatch
Front area explored longer lagged-exposure periods and
found that a 14-day lagged cumulative moving average of
10 g/m3 PM2.5 was associated with a 13.1% (95% CI
1.3% to 26.2%) increase in heart failure admissions.119
Cerebrovascular Disease
Among the cohort studies that provided pertinent results, the
Women’s Health Initiative reported significant increases in
both nonfatal stroke (hazard ratio 1.28, 95% CI 1.02 to 1.61)
and fatal cerebrovascular disease (hazard ratio 1.83, 95% CI
1.11 to 3.00) per 10-g/m3 elevation in prolonged exposure
to PM2.5.72 However, no significant association between
stroke mortality and PM air pollution was found in the ACS
study.67
Several studies have also reported small but statistically
significant associations between short-term PM exposure and
cerebrovascular disease. Daily time-series studies of stroke
mortality in Seoul, Korea,120,121 observed that elevated air
pollution (including measures of PM, NO2, CO, and O3) was
associated with increases in stroke mortality. When analyzed
separately by stroke type,121 the pollution association was
associated with ischemic but not hemorrhagic stroke. Risk of
stroke mortality was also associated with daily increases in
PM10 and NO2 in Shanghai, China.56 A daily time-series
study in Helsinki, Finland,122 found that PM2.5 and CO were
associated with stroke mortality in the warm but not the cold
seasons. Several studies have also observed increased stroke
or cerebrovascular hospital admissions associated with in-
creased exposure to PM or related pollutants.31,38,40,46,123–125
For example, a study of hospital admissions for Medicare
recipients in 9 US cities125 found that several measures of air
pollution (PM10, CO, NO2, and SO2) 0 to 2 days before
admission were associated with ischemic but not hemorrhagic
stroke. Studies of ischemic stroke and transient ischemic
attacks based on population-based surveillance have also
been conducted in Dijon, France,126 where O3 exposure (but
not PM10) was associated with ischemic stroke, and in Corpus
Christi, Tex,127 where both PM2.5 and O3 were associated
with ischemic strokes and transient ischemic attacks.
Peripheral Arterial and Venous Diseases
There have been only a few studies that have explored a
relationship between air pollution and peripheral vascular dis-
eases. Studies using Medicare data for 204 US counties observed
nearly statistically significant positive associations between
daily changes in measures of PM pollution and hospitalizations
for peripheral vascular diseases.103,104 The ACS cohort found no
association between other atherosclerotic and aortic aneurysm
deaths and long-term PM2.5 exposure.67
Recently, a case-control study from the Lombardy region
of Italy found a 70% increase in risk of deep vein thrombosis
per 10-g/m3 elevation in long-term PM10 level.128 This is the
first observation that particulate air pollution can enhance
coagulation and thrombosis risk in a manner that adversely
affects the venous circulation in addition to the arterial
cardiovascular system.
Cardiac Arrhythmias and Arrest
Several studies have observed associations between fine PM
and related pollutants and cardiac arrhythmias, often based on
data from implanted cardioverter-defibrillators.129–136 How-
ever, no clear pollution-related associations were observed in
studies from a relatively clean metropolitan area, Vancouver,
British Columbia, Canada,137,138 or from a relatively large
study in Atlanta, Ga.139 Similarly, pollution-related associa-
tions have been observed with cardiac arrest in Rome,
Italy,140 and Indianapolis, Ind,141 but not in Seattle,
Wash.142,143 The mixed results may reflect different PM
compositions due to different sources or variations among the
methods used.
Evidence Summary
On the basis of the available epidemiological studies that
have reported the associations between PM exposures with
specific subsets of cardiovascular outcomes (morbidity, mor-
tality, or hospitalizations), the existing level of overall evi-
dence is strong for an effect of PM on ischemic heart disease,
moderate (yet growing) for heart failure and ischemic stroke,
and modest or mixed for peripheral vascular and cardiac
arrhythmia/arrest (Table 6).
Ambient Air Pollution and Subclinical
Pathophysiological Responses in
Human Populations
It is likely that many subclinical physiological changes occur
in individuals in response to PM2.5 exposures that do not
become overtly manifest as a cardiovascular event (eg, death
or MI). The illustration of these more subtle responses
bolsters the plausibility of the observable outcome associa-
tions and provides insight into the pathways whereby air
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pollutants mediate CVDs. The “Biological Mechanisms”
section discusses the hypothesized global pathways and
reviews the studies related to the fundamental cellular/
molecular mechanisms elucidated by controlled human and
animal exposures and toxicological/basic science experi-
ments. The following section reviews the recent evidence that
ambient exposure to air pollution can mediate potentially
harmful subclinical cardiovascular effects. In general, many
positive associations are found (Table 6). Numerous complex
interactions between variations in the characteristics, sources,
and chemistry of the particles, coupled with diversity in time
frames, mixtures of exposures, and degrees of individual
susceptibility, likely explain some of the disparity among
findings.
Systemic Inflammation
There is evidence that under some circumstances, exposure to
ambient PM can be associated with elevated circulating
proinflammatory biomarkers that are indicative of a systemic
response after PM air pollution inhalation that is not limited
to the confines of the lung. Early reports found associations
with day-to-day variation in acute-phase proteins, such as
C-reactive protein (CRP), fibrinogen, or white blood cell
counts,144–147 as reviewed previously.1 Limited evidence on
the association between cumulative PM exposures and fibrin-
ogen levels and counts of platelets and white blood cells was
also available.148
A number of more recent studies have reported positive
associations with short-term ambient PM exposure and day-
to-day elevations in inflammatory markers. These include
increases in CRP in an elderly population149 and individuals
with coronary atherosclerosis150; CRP and fibrinogen in
young adults151 and elderly overweight individuals152; and
CRP, tumor necrosis factor- (TNF-), and interleukin
(IL)-1 in children.153 Recent evidence has also been found
for an upregulation of circulating soluble adhesion molecules
(eg, intercellular adhesion molecule-1) in 92 Boston, Mass–
area individuals with diabetes154 and 57 male subjects with
coronary artery disease in Germany.150 In a larger analysis of
1003 MI survivors, also in Germany, CRP was not related to
PM exposure; however, ambient particle number concentra-
tion and PM10 were associated with increased IL-6 and
fibrinogen, respectively.155 Short-term levels of in-vehicle
PM2.5 have also been linked to increases in CRP among
healthy highway patrol troopers.156 In a follow-up analysis,
elevations in certain particulate components of traffic pollu-
tion (eg, chromium) were associated with increased white
blood cell counts and increased IL-6 levels.157 Short-term
changes in ambient PM levels have also been linked to acute
(1 to 3 days later) alterations in biomarkers of inflammation,
oxidative stress, and platelet activation among elderly adults
with coronary artery disease living in retirement communities
in Los Angeles, Calif.158,159 Pollutants associated with pri-
mary combustion (eg, elemental and black carbon, primary
organic carbon) and UFPs rather than PM2.5 appeared to be
strongly associated with adverse responses in this population.
Regarding more long-term exposures,160 a positive associ-
ation between white blood cell count and estimated long-term
1-year exposure to PM10 was reported in the Third National
Health and Nutrition Examination Survey. Among 4814
adults in Germany, small increases in annual mean PM2.5 (3.9
g/m3) were associated with increases in high-sensitivity
CRP by 23.9% and in fibrinogen by 3.9% among men only.
Estimated long-term traffic exposure was not related to
inflammatory changes in either sex.161
Several studies, including some with improved exposure
assessment,162 some that included analyses of large popula-
tion cohorts,163,164 and a recent evaluation of long-term
annual PM10 levels in England,165 have not found a relation-
ship between particulate exposure and inflammation. It is
Table 6. Overall Summary of Epidemiological Evidence of the
Cardiovascular Effects of PM2.5, Traffic-Related, or
Combustion-Related Air Pollution Exposure at Ambient Levels
Health Outcomes
Short-Term
Exposure
(Days)
Longer-Term
Exposure (Months to
Years)
Clinical cardiovascular end
points from epidemiological
studies at ambient
pollution concentrations
Cardiovascular mortality 111 111
Cardiovascular hospitalizations 111 1
Ischemic heart disease* 111 111
Heart failure* 11 1
Ischemic stroke* 11 1
Vascular diseases 1 1†
Cardiac arrhythmia/cardiac arrest 1 1
Subclinical cardiovascular
end points and/or
surrogate measures in
human studies
Surrogate markers of
atherosclerosis
N/A 1
Systemic inflammation 11 1
Systemic oxidative stress 1
Endothelial cell activation/
blood coagulation
11 1
Vascular/endothelial
dysfunction
11
BP 11
Altered HRV 111 1
Cardiac ischemia 1
Arrhythmias 1
The arrows are not indicators of the relative size of the association but
represent a qualitative assessment based on the consensus of the writing
group of the strength of the epidemiological evidence based on the number
and/or quality, as well as the consistency, of the relevant epidemiological
studies.
111 Indicates strong overall epidemiological evidence.
11 Indicates moderate overall epidemiological evidence.
1 Indicates some but limited or weak available epidemiological evidence.
Blank indicates lack of evidence.
N/A indicates not applicable.
*Categories include fatal and nonfatal events.
†Deep venous thrombosis only.
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conceivable that differences in the magnitude or character of
the inflammatory response will occur because of variations in
the particulate chemistry and duration/intensity of exposures.
Certain individuals may also be more susceptible. The evi-
dence suggests that subjects with underlying cardiovascular
risk factors and the metabolic syndrome may exhibit stronger
associations.152,160,166 Conversely, antiinflammatory medica-
tions such as statins may mitigate the actions of ambient
particles.152,155 All together, there is some evidence for a
positive association between recent and long-term PM expo-
sure and a systemic proinflammatory response; nevertheless,
there is variation in the strength and consistency of changes
among the variety of biomarkers and patient populations
evaluated (Table 6).
Systemic Oxidative Stress
A state of oxidative stress refers to a condition in which levels
of free radicals or reactive oxygen/nitrogen species (eg, O2,
H2O2, ONOO) are higher than normal (eg, healthy individ-
uals in whom they are countered by homeostatic processes
such as antioxidants) and thus are capable of exerting many
adverse biological effects (eg, lipid/protein/deoxyribonucleic
acid [DNA] oxidation, initiation of proinflammatory cas-
cades). Although many biomarkers of differing systemic
responses are available (eg, lipid or protein oxidation prod-
ucts), oxidative stress may occur at the local cellular/tissue
level and not be directly observable by circulating markers. In
addition, oxidative stress is often induced by and elicits
inflammatory processes. The 2 processes are biologically
linked. Therefore, human studies investigating the effect of
PM on oxidative stress per se are difficult to perform. Only a
few studies have directly investigated the occurrence of
systemic oxidative stress in humans in relation to ambient PM
exposure. Three studies of young adults conducted in Den-
mark demonstrated elevations in biomarkers of protein, lipid,
or DNA oxidation in relation to PM exposure from traffic
sources.167–169 In a study of 76 young adults from Taipei,
Taiwan,151 the investigators found evidence of increased
levels of 8-hydroxy-2-deoxyguanosine adducts in DNA in
relation to short-term elevations in ambient PM. Two studies
have also demonstrated increases in plasma homocysteine,
evidence that exposure to ambient PM can elevate this
circulating mediator of oxidative stress.170,171 Finally,
Romieu et al172 found that dietary supplementation with
omega-3 polyunsaturated fatty acids might be capable of
altering the systemic oxidative stress response (reduction in
copper/zinc superoxide dismutase and glutathione) induced
by air pollutants among residents living in a nursing home in
Mexico City, Mexico. Because of the relatively small number
of studies, more investigation is required to make firm
conclusions and to understand the nature of the systemic
oxidative stress response potentially induced by ambient PM
(Table 6).
Thrombosis and Coagulation
Early reports indicated that increased plasma viscosity144
and elevated concentrations of fibrinogen146 are associated
with short-term changes in ambient PM concentrations.
More recent evidence was found for an upregulation of
circulating von Willebrand factor in 57 male subjects with
coronary artery disease in Germany150 and 92 Boston-area
individuals with diabetes.154 Riediker157 found that com-
ponents of in-vehicle PM2.5 were also related to increased
von Willebrand factor and decreased protein C among
highway patrol troopers. In the Atherosclerosis Risk in
Communities study, a 12.8-g/m3 elevation in ambient
PM10 was associated with a 3.9% higher von Willebrand
factor level,173 but only among those with diabetes. There
was no linkage between PM10 exposure and fibrinogen or
white blood cell levels.
Alterations in other markers that indicate changes in
thrombosis, fibrinolysis, and global coagulation have also
been reported. An immediate elevation in soluble CD40-
ligand concentration, possibly reflecting platelet activa-
tion, recently was found to be related to ambient UFP and
accumulation-mode particle (PM0.1–1.0) levels in patients
with coronary artery disease.155 Ambient PM10 levels have
also been associated with augmented platelet aggregation
24 to 96 hours after exposure among healthy adults.174 In
this study, there were no concomitant observable changes
in thrombin generation, CRP, or fibrinogen induced by
PM10. Increases in plasminogen activator inhibitor-1 and
fibrinogen levels have been noted in healthy subjects,151 as
well as elevated plasminogen activator inhibitor-1 in
patients with coronary artery disease only,175 in association
with ambient PM levels in Taipei. Chronic indoor pollu-
tion exposure to biomass cooking in rural India has also
been associated with elevated circulating markers of plate-
let activation.176 Recently, Baccarelli et al128,177 demon-
strated in healthy subjects and among individuals with
deep venous thrombosis living in the Lombardy region of
Italy that prothrombin time was shortened in relation to
recent and long-term ambient PM10 concentrations. Nev-
ertheless, some studies found no effects of ambient pollu-
tion,178 nor have significant changes been reported among
all the biomarkers or subgroups of individuals investigat-
ed.150,154,170,173 Similar to the study on systemic inflamma-
tion, the results related to thrombosis/coagulation are quite
variable given the differences in study designs, patients,
biomarkers evaluated, and pollutants; however, these ad-
verse effects appear somewhat more consistent among
higher-risk individuals (Table 6).
Systemic and Pulmonary Arterial BP
Several studies have reported that higher daily PM levels
are related to acute increases in systemic arterial BP
(approximately a 1- to 4-mm Hg increase per 10-g/m3
elevation in PM).179 –184 In a small study of patients with
severe heart failure,185 pulmonary artery and right ventric-
ular diastolic BP were found to increase slightly in relation
to same-day levels of PM. Chronic exposure to elevated
PM2.5 was associated with increased levels of circulating
endothelin (ET)-1 and elevated mean pulmonary arterial
pressure in children living in Mexico City.186 These results may
explain in part the risk for heart failure exacerbations due to PM
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exposure; however, not all studies of systemic arterial BP have
been positive.187–189
Recently, Dvonch et al190 demonstrated significant as-
sociations between increases in systolic BP and daily
elevations in PM2.5 across 347 adults living in 3 distinct
communities within metropolitan Detroit, Mich. Much
larger effects were observed 2 to 5 days after higher PM2.5
levels within a specific urban location of southwest Detroit
(8.6 mm Hg systolic BP increase per 10-g/m3 PM2.5) than
throughout the entire region or cohort (3.2 mm Hg). This
suggests that specific air pollution sources and components
contribute significantly to the potential for PM exposure to
raise BP. Interestingly, it was recently reported in a
crossover study of 15 healthy individuals that systolic BP
was significantly lower (114 versus 121 mm Hg) during a
2-hour walk in Beijing, China, while the subjects were
wearing a high-efficiency particulate-filter facemask than
when they were not protected.191 Wearing the facemask
was also associated with increased HRV, which suggests
that the rapid BP-raising effects of particle inhalation may
be mediated through the autonomic nervous system (ANS).
In a similar fashion,192 reducing exposure to particulate
pollution from cooking stoves was shown to be associated
with lower systolic (3.7 mm Hg, 95% CI 8.1 to
0.6 mm Hg) and diastolic (3.0 mm Hg, 95% CI 5.7 to
0.4 mm Hg) BP among Guatemalan women than among
control subjects after an average of 293 days. These
findings demonstrate that indoor sources of PM (eg,
cooking, biomass) may have important cardiovascular
health consequences and that reductions in particulate
exposure are capable of lowering BP, and they suggest that
chronic exposure to PM air pollution may alter long-term
basal BP levels. Even given the rapid variability of BP on a
short-term basis and the numerous factors involved in determin-
ing individual responses (eg, patient susceptibility, PM compo-
sition, and time frames of exposure), overall, it appears that
ambient PM can adversely affect systemic hemodynamics, at
least under certain circumstances (Table 6).
Vascular Function
In the first ambient PM study related to changes in
vascular function, O’Neill et al193 reported that both
endothelium-dependent and -independent vasodilation
were blunted in relation to air pollution levels in Boston.
The largest changes occurred in association with sulfate
and black carbon, suggestive of coal-burning and traffic
sources, respectively. Significant adverse responses were
observed within 1 day yet were still present and slightly
more robust up to 6 days after exposure. Moreover, the
adverse responses occurred solely among diabetic individ-
uals and not in patients at risk for diabetes mellitus. Two
other studies184,194 also demonstrated impaired vascular
function due to short-term changes in ambient PM among
diabetic patients. In the study by Schneider et al,194
endothelium-dependent vasodilation was blunted during
the first day, whereas small-artery compliance was im-
paired 1 to 3 days after elevated ambient PM levels.
Interestingly, higher concentrations of blood myeloperox-
idase were related to a greater degree of endothelial
dysfunction, which suggests that white blood cell sources
of reactive oxygen species (ROS) may be involved.
In healthy adults, very short-term exposure to elevated
levels of ambient PM from traffic sources while exercising
for 30 minutes near roadways195 and when resting by bus
stops for 2 hours196 has been related to impaired endothe-
lium-dependent vasodilation. Daily changes in ambient
gaseous pollutants (SO2 and NOx) in Paris, France, have
also been associated with impaired endothelium-dependent
vasodilation among nonsmoking men.197 Finally, indoor
particulate air pollution may also be harmful to vascular
function. Bra¨uner and colleagues198 recently reported that
reductions in 48-hour PM2.5 levels due to filtering of air in
subjects’ homes resulted in improved microvascular vas-
cular function among elderly subjects. Nevertheless,
changes in short-term ambient PM levels have not been
linked with impaired conduit197 or microvascular178 endo-
thelial function in all studies. Even when the few negative
studies are considered, the overall evidence supports the
concept that ambient PM is capable of impairing vascular
function, particularly among higher-risk individuals (eg,
those with diabetes) and after traffic-related exposure
(Table 6).
Atherosclerosis
A few cross-sectional studies have reported an association
between measures of atherosclerosis in humans and long-
term exposures to ambient air pollution levels. The first study
to demonstrate this relationship was an analysis of data from
798 participants in 2 clinical trials conducted in the Los
Angeles area. A cross-sectional contrast in exposure of 10
g/m3 PM2.5 was associated with an adjusted nonsignificant
4.2% (95% CI 0.2% to 8.9%) increase in common carotid
intima-media thickness199; however, in certain subgroups of
patients, such as women, the effect was much larger (13.8%,
95% CI 4.0% to 24.5%). In a population-based sample of
4494 subjects from Germany,200 it was found that residential
proximity to major roadways was associated with increased
coronary artery calcification. A reduction in distance from a
major road by half was associated with a 7% (95% CI 0.1%
to 14.4%) higher coronary artery calcium score. Proximity to
traffic was also related to an increased risk for peripheral
artery disease in women but not men.201 In an analysis of 3
measures of subclinical disease (carotid intima-media thick-
ness, coronary calcium, and ankle-brachial index) among
5172 adults from the Multi-Ethnic Study of Atherosclerosis,
only common carotid intima-media thickness was modestly
(yet significantly) associated with 20-year exposure to
PM2.5.202 In a related study from the same cohort, abdominal
aortic calcium was associated with long-term PM2.5 exposure,
especially for residentially stable participants who resided
near a PM2.5 monitor.203 Although it appears that long-term
exposure to higher levels of ambient PM might accelerate the
progression of atherosclerosis, more investigations are
needed (Table 6).
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Heart Rate Variability
Numerous studies have continued to explore associations
between daily changes in PM air pollution exposure and
alterations (typically reductions) in HRV metrics, putative
markers of cardiac autonomic balance.129,149,156,204–242 Recent
observations in the Normative Aging Study cohort have
shown strong effect modification of the PM-HRV relation-
ship by obesity and genes that modulate endogenous oxida-
tive stress or xenobiotic metabolism, such as glutathione
S-transferase M1, methylenetetrahydrofolate reductase, and
the hemochromatosis gene.207,243,244 Additional findings
suggest protective effects of statins, dietary antioxidants,
and B vitamins, as well as omega-3 polyunsaturated fatty
acids.205,207,215,243,244 These results suggest that pathways
that reduce endogenous oxidative stress have a protective
effect that mitigates reductions in HRV due to ambient PM
exposure.
However, the overall results are not entirely consistent.
Some studies have reported increases in HRV mediated by
PM, specifically among younger healthy people and patients
with chronic obstructive lung disease.156,208,216 Nevertheless,
the general pattern suggests that PM exposure is associated
with increased heart rate and reductions in most indices of
HRV among older or susceptible individuals, such as those
with obesity and the metabolic syndrome. Typically, time-
domain measures (eg, standard deviation of normal RR
intervals) and total power are reduced within hours after
exposure. Most, but not all, pertinent studies have also found
that the largest reduction in power is within the high-
frequency domain. In sum, these observations provide some
evidence that ambient PM air pollution exposure rapidly
reduces HRV, a surrogate marker for a worse cardiovascular
prognosis (Table 6). Although studies corroborating changes
in autonomic activity by other methods (eg, microneurogra-
phy or norepinephrine kinetics) have not been performed, the
HRV findings are perhaps reflective of the instigation of a
generalized cardiovascular autonomic imbalance due to rela-
tively greater parasympathetic than sympathetic nervous sys-
tem withdrawal.
Cardiac Ischemia and
Repolarization Abnormalities
There has been limited direct evidence for the actual induc-
tion of cardiac ischemia or repolarization abnormalities in the
electrocardiogram (ECG) by exposure to ambient levels of
PM.223,245 Recent follow-up analyses from the initial ULTRA
study (Exposure and Risk Assessment for Fine and Ultrafine
Particles in Ambient Air)245 suggested that traffic-related
combustion pollutants were most strongly related to the
promotion of ST-segment depression among elderly non-
smokers during exercise stress testing.246 Moreover, even
very acute PM2.5 exposure within the past 1 or 4 hours has
been associated with cardiac ischemia during exercise.247
New findings support these associations in elderly subjects248
and in patients with coronary artery disease in Boston.249 In
the latter study, traffic-related PM was most strongly related
to the incidence of ST-segment depression during 24-hour
Holter monitoring, and the risk for ischemia was greatest
within the first month after a cardiac event among patients
with diabetes. Overall, there is a modest level of evidence that
PM exposure can promote cardiac ischemia in susceptible
individuals (Table 6).
Epigenetic Changes
There have been relatively few studies examining gene–air
pollution exposure interactions, and most have done so
while investigating a small number of loci for genetic
polymorphisms. Although some studies have suggested
greater air pollution susceptibility with one or another
genomic polymorphism,207,243,244 few have evaluated the
potential for epigenetic changes after exposures. Reduced
levels of DNA methylation have been linked to aging,
oxidative stress, and CVD. Recently, Baccarelli et al250
have shown among 718 elderly participants in the Norma-
tive Aging Study that short-term exposures (over 1 to 7
days) to PM2.5 and black carbon are associated with
decreased “global” DNA methylation in long interspersed
nucleotide elements. It was posited that oxidative stress
from air pollution exposure could have interfered with the
capacity for methyltransferases to interact with DNA or
altered the expression of genes involved in the methylation
process. This observed effect of pollution exposure was
analogous to changes seen with 3.4 years of aging in the
cohort. Additional findings among workers in a furnace
steel plant support these observations.251 Nevertheless, the
mechanisms involved and the cardiovascular implications
of these preliminary, although provocative, epigenetic
changes require more investigation.
Traditional Cardiovascular Risk Factors
In addition to the fact that individuals with traditional risk
factors are likely to be at higher risk for cardiovascular
events due to PM exposure, air pollutants may also
promote the development of these risk factors over a
prolonged period of time. Few published studies have
investigated this possibility. A report from the Multi-
Ethnic Study of Atherosclerosis has demonstrated that
residential proximity to major roadways was associated
with a higher left ventricular mass index as measured by
cardiac magnetic resonance imaging.252 The degree of
increase was analogous to a 5.6-mm Hg increase in sys-
tolic BP among the study participants. This suggests that
traffic-related exposures may have increased left ventric-
ular mass by chronically elevating systemic arterial BP, a
common cause of left ventricular hypertrophy. However,
other mechanisms cannot be excluded, such as systemic
inflammation and oxidative stress, which could potentially
activate neurohormonal pathways (eg, ANS imbalance,
renin-angiotensin system) that could directly mediate such
a finding. In addition, a recent study of adults older than 30
years of age (n132 224) participating in the National
Health Interview Survey reported a significant association
between self-reported hypertension and estimated annual
PM2.5 exposure using US EPA monitoring data.253 A
10-g/m3 elevation in PM2.5 was associated with an
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adjusted odds ratio of 1.05 (CI 1.00 to 1.10) for the
presence of hypertension. The increase in risk was found
only among non-Hispanic whites. These studies provide
some initial evidence that longer-term PM exposures may
augment the risk for developing chronically elevated BP
levels or even overt hypertension.
Brook et al254 have also demonstrated a novel relation-
ship between a metric of long-term traffic exposure (NO2
level by residence) and the odds of having the diagnosis of
diabetes mellitus among patients in 2 respiratory clinics in
Ontario, Canada. In women only, the odds ratio of diabetes
was 1.04 (95% CI 1.00 to 1.08) for each increase of 1 parts
per billion (ppb) of NO2. Across the interquartile range (4
ppb NO2), exposures were associated with nearly a 17%
increase in odds for diabetes mellitus. The first biological
support for this finding comes from a study in Iran that
demonstrated that the previous 7-day-long exposure to
PM10 was independently associated with worse metabolic
insulin sensitivity among 374 children 10 to 18 years of
age.255 These findings suggest that the systemic proinflam-
matory and oxidative responses due to long-term PM air
pollution exposure could potentially increase the risk for
developing clinically important aspects of the metabolic
syndrome, such as hypertension and diabetes mellitus.
Further studies in this regard are warranted.
Evidence Summary
Table 6 provides a consensus qualitative synopsis based on
the expert opinions of the writing group members of the
overall level of existing support, linking each surrogate or
intermediate cardiovascular outcome with exposures to PM at
ambient concentrations, based solely on the database of
observational studies.
Additional Epidemiological Findings and
Areas of Continued Research
Responsible Sources and Pollution Constituents
Although PM concentration (mass per cubic meter) has
been associated with cardiovascular events in numerous
studies, the specific particulate constituents and the
sources responsible remain less clear. Despite the fact that
it is a difficult undertaking, several epidemiological stud-
ies have attempted to identify the culprit components
within the PM mixtures. With regard to PM-associated
inorganic ions (nitrate and sulfate), it has been suggested
that the overall toxicological data do not clearly implicate
these compounds as responsible for mediating the cardio-
vascular health effects of PM2.5.256 Nevertheless, sulfate
particles have been associated with cardiopulmonary mor-
tality in the ACS and Harvard Six Cities studies.62,68 A
recent time-series analysis among 25 US cities found that
cardiovascular risk was increased when PM mass con-
tained a higher proportion of sulfate, as well as some
metals (aluminum, arsenic, silicon, and nickel).257 It is
possible that these positive findings represent sulfate
serving as a marker for an effect mediated by a toxic PM
mixture derived from commonly associated sources (eg,
coal combustion). Nevertheless, a direct role for particle
sulfate in causing cardiovascular events cannot be ex-
cluded entirely.256
In California, short-term exposures to several different PM
constituents that likely reflect combustion-derived particu-
lates, including organic and elemental carbon and nitrates,
were most strongly associated with higher cardiovascular
mortality.258 Certain metals (zinc, titanium, potassium, and
iron) and sulfate levels in the winter months were also
positively related. Similarly, ambient levels of organic and
elemental carbon have been most strongly linked among PM
constituents with hospitalizations for CVDs in multipollutant
models in a study among 119 US cities.259 Finally, PM2.5
composed of higher levels of elemental carbon, along with
the metals nickel and vanadium,48 has also been linked with
greater risks for cardiovascular hospitalizations.260 These
results support that the chemistry or composition of the PM2.5
(eg, organic/elemental carbon and certain metals) along with
the responsible source from which these mixtures are derived
(eg, fresh combustion, traffic) may play important roles in
determining the risk for cardiovascular events. However,
the extent to which these constituents mediate specific
responses, alone or together, and their importance beyond
the concentration of PM2.5 mass alone represent an area of
active research that requires more investigation to reach
firm conclusions.
Many experiments have demonstrated the especially toxic
properties and strong oxidizing potential of the smallest
particle sizes (eg, UFP) and of the specific chemical species
typically rich within this size fraction (eg, transition metals,
organic compounds, and semiquinones).261 Although some
epidemiological evidence suggests that exposure to ultrafine
compounds17 may be associated with higher cardiovascular
risk (eg, an elevation of UFP count by 9748/cm3 has been
associated with an increase in cardiovascular mortality of
approximately 3% within 4 days in Erfurt, Germany262) and
adverse responses,158,159 there have been few such studies
because they are challenging to conduct, for numerous
reasons. Moreover, there are few UFP monitors, and the
levels measured at regional sites may not accurately reflect
an individual person’s exposure because of marked spatial
heterogeneity, because the concentrations are dominated
by local point sources of fresh combustion (eg, roadways).
This could help explain some of the previously negative
study findings.116
Similarly, coarse particulates between 0.25 and 1.0 m
in diameter may affect the cardiovascular system,221,264,265
and although the available data related to hard events and
cardiovascular mortality have suggested a relation-
ship,265,266 recent findings have been less consistent.104 In
the most recent time-series analysis of 112 US cities,
coarse PM was independently associated with elevated
all-cause, stroke, and pulmonary, but not cardiovascular,
mortality after controlling for PM2.5.43 Coarse PM was also
not associated with either fatal or nonfatal cardiovascular
events after controlling for PM2.5 levels in the Nurses’
Health Study267 or the Women’s Health Initiative cohort
analyses.72 Additional research is required to establish
whether there are independent health effects of the other
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particulate size fractions beyond those posed by fine
particles. On the other hand, PM2.5 mass concentration is
the metric most consistently associated with cardiovascu-
lar morbidity and mortality. It remains to be determined
whether this reflects limitations of available data, the
long-lived and regionally homogenous atmospheric nature
of PM2.5, that few studies have investigated the indepen-
dent effects of the other sizes, difficulties in performing
epidemiology studies with adequate UFP exposure esti-
mates, or that specific constituents within the fine PM
fraction (or another unidentified agent correlated with that
fraction) are actually responsible for causing cardiovascu-
lar events. Although particles 0.1 m (ie, UFPs) do make
up a small fraction of PM2.5 mass, the correlation between
UFP particle number and total PM2.5 mass concentration is
often weak. Because of their minute size, UFPs make up
only a small portion of the total PM2.5 mass, even though
they represent the largest actual number of particles within
fine PM. They also have the highest surface area and a
differing surface chemistry. Therefore, changes in the
underlying UFP concentration do not likely account for or
explain the linkages between PM2.5 mass concentration
and cardiovascular events observed in large multicity
studies. The overall epidemiological evidence thus indi-
cates that fine PM poses an independent cardiovascular
risk and that any putative effects of these other size
fractions cannot fully explain the observed PM2.5– cardio-
vascular morbidity/mortality relationship.
On the other hand, there is mounting evidence for a
distinctive role played by motor vehicle traffic–related expo-
sures in elevating cardiovascular risk.108,111,268,269 Lipfert et
al76,77 interpreted the results of their analysis of the Veterans
Affairs hypertensive male cohort as suggesting that traffic
density was a more “significant and robust predictor of
survival in this cohort” than PM2.5. Analyses of the Oslo,81
Dutch,82 AHSMOG,74,75,88 French PAARC,79 and German
women cohorts80 and related studies from areas in the United
Kingdom,270 Canada,271 Norway,272 and Rome273 found that
measures that often indicate traffic-related exposure (NO2,
NOx, traffic density, and living near major roads) were also
associated with increased mortality. Long-term 5-year aver-
age traffic-generated air pollution exposure has been associ-
ated with an increased risk of fatal MI (odds ratio 1.23, 95%
CI 1.15 to 1.32 per 31-g/m3 increase in NO2) but not
nonfatal MI in Stockholm County, Sweden.274 The results
mirror the results of several cohort studies72,73 that found that
air pollution exposures appeared to be more strongly linked
with cardiovascular mortality than nonfatal events. Recently,
an analysis from a cohort in the Netherlands demonstrated
that several metrics of traffic-related air pollution exposure
remained significantly associated with increased risk for
cardiovascular events even after adjustment for higher levels
of traffic noise.275
The effect of long-term traffic-related exposure on inci-
dence of fatal and nonfatal coronary heart disease was
recently assessed after adjustment for background air pollut-
ants and cardiovascular risk factors in 13 309 adults in the
Atherosclerosis Risk in Communities study.276 Interestingly,
background chronic ambient PM2.5 concentrations were not
related to the interpolated traffic exposure levels or to heart
disease outcomes, which supports the highly localized nature
of traffic sources of exposure. After 13 years of follow-up in
4 US communities, individuals residing within the highest
quartile of traffic density had a relative risk of 1.32 (95% CI
1.06 to 1.65) for fatal and nonfatal heart disease events.
Despite multiple statistical adjustments, the investigators also
acknowledged the possibility for residual confounding as a
potential source of bias. The specific traffic-related pollution
components, such as UFP or gaseous-phase chemicals (eg,
SVOCs), that are responsible for the positive findings among
these studies remain unknown. The close proximity to road-
ways within these epidemiological studies (eg, 400 m)
required to observe an association with elevated cardiovas-
cular risk, however, matches the atmospheric fate of these
shorter-lived pollutants. The findings may thus suggest the
existence of cardiovascular health effects mediated by spe-
cific air pollutants rather than PM2.5 per se. There is room for
improvement in assessment of traffic exposures in epidemi-
ological research, and better approaches are now being
incorporated into research projects, such as accounting for
associated factors (eg, noise or spatial autocorrelation with
socioeconomic status).275,277
Geographic differences in cardiovascular risk due to PM
have also been observed across US regions, with more
consistent or stronger effects observed in Eastern versus
Western states.71,103,257 Differences between North American
and European cities have also been reported.61 PM exposures
are typically, but not always,258 associated with larger effects
during warmer months (spring through fall) than in the
winter.45,103,257 Variations in pollution characteristics (eg,
sulfate), time spent outdoors, air conditioning usage and
particle penetration indoors, ambient temperature and mete-
orology, and mobile (eg, diesel) or stationary (eg, coal
combustion) sources of exposure may help explain these
differences. Finally, variations in the cardiovascular risk
posed by PM may also occur because of heterogeneity in the
metric of exposure, such as personal versus background
regional,25 indoor versus outdoor sources, and differences in
intracity versus intercity gradients.69 A better understanding
of the responsible constituents and sources is important and
could potentially lead to more targeted and effective regula-
tions. On the other hand, finding continued evidence that the
adverse cardiovascular health effects cannot be linked con-
clusively to a particular or specific chemical species or source
of pollution but rather that they occur in response to a variety
of exposure types or mixtures would support the present-day
policy of reducing exposure to overall fine particulate mass to
achieve public health benefits.
Time Course and
Concentration-Response Relationships
Many studies have demonstrated that PM air pollution expo-
sure does not simply advance the mortality by a few days of
critically ill individuals who would have otherwise died (eg,
mortality displacement or “harvesting”).278,279 There also
appears to be a monotonic (eg, linear or log-linear)
concentration-response relationship between PM2.5 and mor-
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tality risk observed in cohort studies that extends below
present-day regulations of 15 g/m3 for mean annual levels,
without a discernable “safe” threshold.67,70,84 Cardiovascular
risk due to particle exposure was also shown to extend below
15 g/m3 in the recent analysis of the Women’s Health
Initiative Observational Study.72 This monotonic association
supports the idea that any reduction in particulate pollution
will translate into health benefits within a population of
people, each with their own individual level of susceptibility.
It also suggests that a larger decrease in PM2.5 exposures will
produce a greater reduction in mortality. Finally, a recent
analysis of the literature provided important new insights into
the nature of the PM exposure-response relationship.280 The
risk for cardiovascular mortality was shown to increase in a
linear fashion across a logarithmically increasing dosage of
inhaled fine-particle levels that ranged from ambient PM air
pollution (0.2 mg/d), through secondhand smoke (1
mg/d), to active smoking (200 mg/d). This means that the
exposure response is extremely steep at very low PM levels
(ie, ambient air pollution) and flattens out at higher concen-
trations (ie, active smoking). This may help explain the
seemingly incongruent and comparatively very high degree
of cardiovascular risk posed by the much lower levels of PM
exposure from ambient pollution and secondhand smoke
versus the much higher doses due to active smoking. Thus,
the cardiovascular system may be extremely sensitive to very
low levels of PM inhalation as encountered with ambient
pollution.
At present, the underlying nature and full scope of the
temporal-risk relationship posed by longer-term PM expo-
sures remain uncertain.2,281 The writing group members did
concur that the available epidemiological studies demonstrate
larger cardiovascular risks posed by more prolonged expo-
sures to higher PM levels than observed over only a few days
(Figure 2). Cohort studies using Cox regression survival
analyses (over months to years) are capable of evaluating a
more complete portion of the temporal-risk relationship than
time-series analyses over only a few days that use Poisson
regression. However, given the lack of complete information,
no conclusions could be drawn on the full magnitude of the
augmented risk posed by chronic exposures, the time window
(a few months versus decades) required to exhibit this
enhanced risk, the underlying biological causes, the extent to
which statistical differences between study types explain the
variations in risk, and whether clinically relevant chronic
CVDs are precipitated by chronic exposures. Some writing
group members believe it is important to differentiate as 2
distinct issues the potentially greater effect of long-term
exposures on increasing the risk for acute events (eg, cardio-
vascular mortality) compared with the putative effect on
initiating or accelerating the development of chronic CVD
processes per se (eg, coronary atherosclerosis). As such, it is
possible that the greater risks observed in cohort studies could
be capturing the fact that repetitive exposures over months or
years augment the risk for sudden cardiovascular events in
susceptible people, without actually worsening an underlying
“chronic” disease process.
On the one hand, the available studies demonstrate that the
majority of the larger risk-effect sizes posed by longer-term
versus short-term exposures appear to be manifested within
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only 1 to 2 years of follow-up. Extending the duration of
follow-up increases cardiovascular risk, but to a progressively
smaller degree over time (Figure 2). The discrepancy in the
effect sizes among study types (eg, cohort versus time-series
studies) could also reflect differences in statistical methodol-
ogies or population susceptibilities.282–284 Recent attempts to
investigate this matter64,84 suggest that the risk for acute
events associated with chronic exposures may be reasonably
well estimated by only the most proximal 1 to 2 years of PM
levels. The most recent time frames of exposure also explain
a substantial portion of the excess cardiovascular risk ob-
served in several cohort studies.70,72,73,83 These findings
bolster the argument that relatively rapid and pliable (and
potentially reversible) biological responses, such as the insti-
gation of plaque instability or the enhanced thrombotic
potential caused by PM-mediated inflammation or endothe-
lial dysfunction (which can occur and abate over only a few
weeks to months), could explain the biology responsible for
this greater relative risk.
On the other hand, cogent alternative arguments can be
made to explain the differences in relative risk between the
cohort and time-series studies. The likely high correlation of
a recent year’s exposure levels with exposures over many
years, as well as the uniform rank ordering of exposure
severity over time among cities, can explain why only a short
period of PM exposure assessment is required to understand
the risk of longer-term exposures. In addition, no studies have
evaluated the potential risks of exposure over decades or a
lifetime. PM augments the ability of traditional risk factors to
accelerate the development of atherosclerosis in experimental
settings. As such, it is also plausible that long-term exposures
may enhance cardiovascular risk to an even greater extent by
increasing an individual’s susceptibility for future cardiovas-
cular events or acute exposures. In addition, the full extent of
this possibility may not be illustrated by the limited follow-up
period (4 to 5 years) of the majority of cohort studies. The
writing group thus agreed that this important issue requires
more investigation.
It is also possible that these 2 explanations are not mutually
exclusive. Furthermore, it cannot be concluded from avail-
able information that a long period of time is required for
reductions in PM levels to translate into a decrease in
cardiovascular risk. On the contrary, reductions in second-
hand smoke285 and PM air pollution levels64,84,90,95 appear to
produce fairly rapid decreases in cardiovascular event rates,
within a few months to years.284 At present, the available data
do not allow for firm conclusions regarding the underlying
biology and the full extent of the potentially nonuniform PM
exposure–to–cardiovascular risk temporal relationship.
Susceptibility to Air Pollution Exposure
Susceptibility refers to a heightened risk for a particular
cardiovascular end point or event to occur compared with the
general population at the same concentration of PM exposure.
Typically, this is indicative of an underlying medical condi-
tion (eg, diabetes) or personal characteristic (eg, old age) that
causes this enhanced risk. This is in contrast to the term
“vulnerability,” which refers to a population of individuals at
greater risk for more frequent or high levels of exposures.
Earlier studies reviewed in the first AHA scientific state-
ment1 suggested that susceptible populations include the
elderly; individuals with diabetes; patients with preexisting
coronary heart disease, chronic lung disease, or heart failure;
and individuals with low education or socioeconomic status.
In the ACS study, current and previous smokers appeared to
be at the same or greater degree of risk.67 Among more recent
studies, the Women’s Health Initiative also reported positive
findings among active smokers and an elevated risk for
cardiovascular mortality induced by PM2.5.72 Conversely,
current smokers were found to be at no increased risk for
cardiovascular mortality in response to PM2.5 exposure in the
Nurses’ Health Study.73 Thus, the effect modification of
smoking status requires more investigation. The APHENA
study of European and North American cities recently con-
firmed that elderly and unemployed individuals are at higher
risk of short-term PM exposure.61 In a multicity time-series
study in Asia, women, the elderly, and individuals with lower
education and socioeconomic status were also shown to be at
elevated risk.286 A few additional studies have reported some
evidence of susceptibility to short-term PM exposures among
older individuals, people with diabetes, and those with a
lower level of education.287–289 Finally, a recent study illus-
trated that present-day levels of PM2.5 likely increase the risk
for a cardiac event within a few days of exposure principally
(or even solely) among individuals with preexisting signifi-
cant coronary artery disease, even if they are seemingly
healthy (eg, without anginal symptoms). Patients without
obstructive lesions on heart catheterization were not at any
risk for PM2.5-induced myocardial events over the short
term.13 This is not surprising, because most acute cardiovas-
cular events occur among individuals with underlying vul-
nerable substrate (eg, unstable plaques) and not in individuals
with normal coronary arteries.
Obesity has been newly recognized as a possible suscep-
tibility factor. Two cohort studies have shown that a greater
body mass index enhances the susceptibility for PM-induced
cardiovascular mortality, at least among women.72,73 Al-
though individuals with diabetes showed a trend toward
greater risk in the Women’s Health Initiative,72 hypertension,
high cholesterol, smoking, elderly age, education, and income
did not alter the risk association. Overall, there appears to be
little effect modification by race, hypercholesterolemia, or BP
among the studies. Finally, sex may also be a risk-effect
modifier. The particularly robust risk estimates of the 2
cohort studies that included only women,72,73 the fact that PM
increased cardiovascular risk in female but not male partici-
pants of the AHSMOG study,75 and the multicity time-series
findings in Asia286 suggest that women may be at greater risk
for cardiovascular mortality related to PM. Further studies are
needed to clarify whether obese individuals and women are
indeed susceptible populations.
Biological Mechanisms
There has been substantial improvement in our understanding
of the biological mechanisms involved in PM-mediated
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cardiovascular effects. Studies before 2004 were reviewed
previously,1 and only some are again discussed here for
contextual background. A number of new experiments have
demonstrated very rapid effects of air pollution, such as
vascular dysfunction, which argues for the existence of
pathways that convey signals systemically within hours of
PM inhalation. On the other hand, there is also support for
chronic biological effects, such as the promotion of athero-
sclerosis. At the molecular level, persuasive evidence sup-
ports an integral role for ROS-dependent pathways at multi-
ple stages, such as in the instigation of pulmonary oxidative
stress, systemic proinflammatory responses, vascular dys-
function, and atherosclerosis. In sum, new studies continue to
support the idea that inhalation of PM can instigate extrapul-
monary effects on the cardiovascular system by 3 general
“intermediary” pathways. These include pathway 1, the
release of proinflammatory mediators (eg, cytokines, acti-
vated immune cells, or platelets) or vasculoactive molecules
(eg, ET, possibly histamine, or microparticles) from lung-
based cells; pathway 2, perturbation of systemic ANS balance
or heart rhythm by particle interactions with lung receptors or
nerves; and pathway 3, potentially the translocation of PM
(ie, UFPs) or particle constituents (organic compounds, met-
als) into the systemic circulation (Figure 3).
Exposure Considerations
Animal and human exposure studies are discussed separately
and apart from the effect of ambient PM because their
methodologies and clinical relevancies vary widely. Con-
trolled exposure studies involve exposing a subject to various
size fractions of PM within a chamber connected to ambient
air (concentrated or nonconcentrated) or a source of aerosol-
ized particles. Virtual impactor systems that deliver concen-
trated ambient particles (CAPs) from “real-world” ambient
air are a commonly used approach for mimicking exposures
to higher levels of ambient particles without requiring inva-
sive methods or the generation of artificial particles.3 Both a
strength and limitation, however, is that CAPs can vary
considerably from day to day in composition. Additionally,
only certain particle size ranges are typically concentrated
(eg, PM from 0.1 to 2.5 m in the fine-CAP system), whereas
Figure 3. Biological pathways linking PM exposure with CVDs. The 3 generalized intermediary pathways and the subsequent specific
biological responses that could be capable of instigating cardiovascular events are shown. MPO indicates myeloperoxidase; PAI, plas-
minogen activator inhibitor; PSNS, parasympathetic nervous system; SNS, sympathetic nervous system; and WBCs, white blood cells.
A question mark (?) indicates a pathway/mechanism with weak or mixed evidence or a mechanism of likely yet primarily theoretical
existence based on the literature.
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ambient air contains a mixture of particle sizes, volatile
organics, and gases that are not concentrated (and can be
lowered). Potential interactions between PM and gaseous
copollutants on health end points are therefore excluded,
unless the latter are reintroduced in an artificial fashion. Other
methods of controlled-inhalation exposures include diesel
engine exhaust (diluted and aged mixtures of high numbers of
fresh combustion UFPs with vapor-phase components), road-
side aerosols, and wood-burning sources. Regarding animal
exposures, intratracheal instillation methods may sometimes
be required because of the limited availability of inhalation
exposure systems. Unfortunately, particle size and surface
characteristics—mostly retained in inhalation systems with
fresh sources of pollution and which may be important in
influencing biological effects—are likely significantly altered
in instillation systems or by methods that use previously
collected particulate. However, the use of carefully modeled
exposures (eg, deposition calculation) and the recognition
that areas of “hot spots” containing markedly higher PM
levels within the lung may occur even during normal inhala-
tion make the results of these experiments potentially rele-
vant.2 Further detailed discussions of exposure considerations
are reviewed elsewhere.290
The protocol details vary considerably among the studies.
Many aspects of exposure, including the duration, concentra-
tion, PM size ranges and composition, and gaseous copollut-
ants, are important to consider. A wide variety of outcomes
may be anticipated depending on the biological pathways
evoked by differing exposures. Moreover, there are multiple
determinants of the subsequent physiological responses, in-
cluding the time frames of investigation, preexisting suscep-
tibility, animal models, and the details of the outcomes
investigated. All of these factors may explain some of the
heterogeneity in the reported study results and must be taken
into consideration when interpreting the findings.
Animal Exposure and Toxicological Studies
Studies that investigate the effects of exposure on susceptible
animals (eg, those with preexisting cardiovascular or meta-
bolic abnormalities) may be preferable in many circum-
stances because of the increasing recognition that the path-
ways underlying the biological effects of PM overlap (ie,
modify and/or enhance) those of conventional cardiovascular
risk factors. Such factors (eg, hypertension or atherosclerosis)
may also be necessary or at least responsible for the evocation
of a more readily observable or robust response. For example,
in the context of systemic oxidative stress or inflammation,
the cellular machinery for the generation of excess ROS and
proinflammatory responses (eg, adhesion molecule and cyto-
kine expression) is already primed or operational in suscep-
tible animals.
Pulmonary Oxidative Stress and Inflammation
The molecular events responsible for triggering pulmonary
oxidative stress and inflammation, along with the interactions
between lung and immune cells, the inhaled PM, and the
protective secretions (eg, surfactant, proteins, and antioxi-
dants), are highly complex,4–6 as reviewed in detail
elsewhere.290a,290b,414 In brief, size, charge, solubility, aggre-
gation, ROS-producing potential, and chemistry play roles in
determining the responses. These include the particle fate (eg,
lung clearance versus retention rates), the nature of the
PM-cell interactions (eg, immune versus lung cell uptake,
host cell responses, and intracellular sequestration/location),
and the dose (likely typically a small percentage of inhaled
PM) and pathways of potential systemic transmission of PM
or its constituents, such as in the circulation [free, intracellu-
lar within circulating cells, (lipo)protein-bound] or via lym-
phatic spread.4,5,290a,290b Because of their nano-scale size,
UFPs may directly enter multiple lung cell types via nonph-
agocytic pathways and adversely affect organelles, such as
mitochondria.6,290a,290b Larger unopsonized fine particles are
more typically taken up by phagocytes through interactions
with innate immunity receptors such as MARCO (macro-
phage receptor with collagenous structure) or other scavenger
receptors.5,290a,290b This may in fact be a protective mecha-
nism that sometimes prevents harmful lung inflammation.
Certain particle compounds may directly generate ROS in
vivo because of their surface chemistry (eg, metals, organic
compounds, and semiquinones) or after bioactivation by
cytochrome P450 systems (eg, polycyclic aromatic hydrocar-
bon conversion to quinones).6,290a,290b A particle surface or
anions present on otherwise more inert particles may disrupt
iron homeostasis in the lung and thereby also generate ROS
via Fenton reactions.291 Other PM constituents may do so
indirectly by the upregulation of endogenous cellular sources
(eg, nicotinamide adenine dinucleotide phosphate [NADPH])
oxidase)292,293 or by perturbing organelle function (eg, mito-
chondria) by taken-up PM components.261 Particle stimula-
tion of irritant and afferent ANS fibers may also play a role
in local and systemic oxidative stress formation.294 Given the
rich antioxidant defenses in the lung fluid, secondarily
generated oxidization products of endogenous molecules (eg,
oxidized phospholipids, proteins) or a reduction in endoge-
nous antioxidants per se may be responsible at least in part for
the state of oxidative stress in the lungs (along with instigat-
ing the subsequent cellular responses) rather than ROS
derived directly from PM and its constituents.
Subsequent to oxidative stress, antioxidant and phase II
defenses may be activated (eg, inducible nitric oxide syn-
thase, glutathione) via transcription factor Nrf2-dependent
pathways.261 When inadequate, pathological oxidative stress
can initiate a variety of pulmonary inflammatory responses.
For example, ROS in the lungs has been shown to augment
the signal transduction of membrane ligand (eg, epidermal
growth factor by disrupting phosphatases) or pattern-
recognition receptors (eg, toll-like receptors [TLR])295–299
and/or stimulate intracellular pathways (eg, mitogen-acti-
vated protein kinases) that lead to the activation of proinflam-
matory transcription factors (eg, nuclear factor-) that
upregulate expression of a variety of cytokines and chemo-
kines.261 Alteration in lung cell redox status may itself
stimulate nuclear factor-. Biological components within
coarse PM could also directly trigger inflammation (eg,
nuclear factor- pathways) by binding to TLR2 or TLR4
receptors or other innate immune pattern-recognition recep-
tors.297 It is also possible that other components of metal-rich
2354 Circulation June 1, 2010
 by guest on M
arch 28, 2018
http://circ.ahajournals.org/
D
ow
nloaded from
 
PM could instigate inflammatory pathways via TLR activa-
tion directly or via the oxidation of endogenous biological
compounds that then serve as TLR ligands.300 Finally, there is
some evidence that PM can activate inflammatory mitogen-
activated protein kinase signaling by angiotensin II receptor–
dependent pathways.295 These inflammatory responses can
also exacerbate the initial oxidative stress [eg, via upregula-
tion of cellular NAD(P)H oxidase] and thus initiate a
positive-feedback cycle.
Available studies support important contributions to pul-
monary inflammation from innate immune cells such as
neutrophils and macrophages (TNF-, IL-6), as well as from
the adaptive immune system, such as T cells (IL-1, IL-4, IL-6,
and IL-10). Although the dominant source of cytokines likely
represents the alveolar macrophages and lung epithelial cells,
the role of other innate and adaptive immune cells cannot be
ruled out.299,301,302 Recently, myeloperoxidase activity was
shown to increase after PM exposure in the same time course
of appearance of cellular inflammation (primarily neutro-
phils) in the lung.303 Gaseous components such as ozone may
also amplify the toxicity of PM.304
Systemic Inflammation
In the context of examining the cardiovascular effects of air
pollution, it is important to consider the inflammatory medi-
ators that are released from lung cells after contact with PM,
because some could conceivably spill over to the general
circulation or increase liver production of acute-phase pro-
teins (eg, CRP, fibrinogen). An increase in circulating proin-
flammatory mediators (eg, activated immune cells, cytokines)
could thus serve as a pathway to instigate adverse effects on
the heart and vasculature. Numerous experiments have dem-
onstrated increased cellular and inflammatory cytokine con-
tent, such as IL-6, IL-1, TNF-, interferon-, and IL-8, of
bronchial fluid and sometimes in circulating blood after acute
exposure to a variety of pollutants.292,305–311
Critical roles for the elevations in systemic and pulmonary
levels of IL-6 and TNF- have been observed after PM
exposure, typically coincident with pulmonary inflamma-
tion.292,302,306,309,311–314 There is at least some evidence that
the degree of pulmonary inflammation and systemic inflam-
mation (IL-6) correlates with the elevation of systemic
cytokines and systemic vascular dysfunction.314 In a 4-week
inhalation exposure to freshly generated diesel exhaust, IL-6
knockout mice did not demonstrate increased cellular inflam-
mation or TNF- in bronchial fluid, which implies a role for
IL-6.315 Consistent with these findings, acute intratracheal
exposure to PM10 resulted in an increase in IL-6, TNF-, and
interferon- in the bronchial fluid.316 However, in this study,
IL-6/ mice showed roughly the same levels of TNF- in
bronchial fluid as wild-type mice, although interferon- was
decreased to control values.316 The results also suggested that
lung macrophages play an important role, because depletion
of these cells abolished the increases in some of the cytokines
and systemic cardiovascular responses. Although our under-
standing of the source of IL-6 and TNF- and their involve-
ment in the systemic inflammatory response after PM expo-
sure remains incomplete, these and other experiments appear
to suggest that at least with PM10 particles, alveolar macro-
phages play a dominant role.309,314,316
Among remaining uncertainties, the upstream signaling
pathway responsible for the recognition of PM components
that in turn produce the systemic inflammation has not been
fully elucidated317; however, there is some evidence with
other particulates and experimental models of lung injury that
ROS generated by NADPH oxidase or pattern-recognition
receptors may modulate some of these responses.292,299,318
NADPH-oxidase knockout mice demonstrated significantly
lower IL-6 and macrophage inflammatory protein-2 re-
sponses to collected PM than wild-type mice.292 Extrapulmo-
nary sources may also be involved in promulgating the
systemic inflammation. PM2.5 exposure in a model of diet-
induced obesity in C57Bl/6 mice for a duration of 24 weeks
resulted in elevations in TNF- and IL-6. In addition, there
were increases in circulating adipokines, such as resistin and
plasminogen activator inhibitor-1.319 The elevation in cyto-
kines, thought to be derived from adipose sources, in addition
to findings of adipose inflammation in that study, raises the
possibility of additional systemic nonpulmonary sources of
such cytokines.
Systemic Oxidative Stress
Numerous in vitro studies have demonstrated activation of
ROS-generating pathways by PM incubation, such as
NADPH oxidases, mitochondrial sources, cytochrome P450
enzymes, and endothelial nitric oxide synthase in cultured
cells or in pulmonary and vascular tissue.293,311,320–329 Similar
to inflammation, the oxidative stress after PM inhalation may
not always stay confined within the lungs.330 The sources of
excess ROS within cardiovascular tissue may include circu-
lating immune cells or cytokines, depletion of defense mech-
anisms (eg, impaired high-density lipoprotein function), ox-
idation of lipoproteins or other plasma constituents,331
activation of ANS pathways,294 or circulating PM constitu-
ents (eg, soluble metals, organic compounds) reaching the
vasculature.261 Activation of ROS-dependent pathways mod-
ulates diverse responses with far-reaching consequences,
including vascular inflammation/activation, atherosclerosis,
impaired basal vasomotor balance, enhanced coagulation/
thrombosis, and platelet activation.290b
Recent experiments have indeed confirmed the existence
of footprints or markers of oxidative stress within the cardio-
vascular system in the in vivo context. Acute-exposure
studies332 have shown a relationship between the vascular
dysfunction in spinotrapezius microvessels and the release of
myeloperoxidase from leukocytes into the vasculature within
only hours after the pulmonary instillation of PM.332 Inter-
estingly, an insoluble particle (TiO2) induced very similar
effects. More long-term studies333 have demonstrated that 10
weeks of exposure to PM2.5 increased superoxide production
in response to angiotensin II and resulted in upregulation of
NAD(P)H oxidase subunits and depletion of tetrahydrobiop-
terin in the vasculature. These effects had functional conse-
quences in terms of increases in systemic vascular resistance
and BP. In another investigation that involved apolipoprotein
E–deficient (ApoE/) fed a high-fat diet, chronic exposure
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to PM2.5 exacerbated vascular oxidant stress and promoted
atherosclerosis progression.334 The proatherogenic effects of
ambient UFPs331 versus PM2.5 in genetically susceptible
ApoE/ mice in a mobile facility close to a Los Angeles
freeway have also been compared. Exposure to UFPs resulted
in an inhibition of the antiinflammatory capacity of plasma
high-density lipoprotein and greater systemic oxidative stress,
as evidenced by increased hepatic malondialdehyde and
upregulation of Nrf2-regulated antioxidant genes.331
Other experiments294 have suggested that ANS imbalance
may play an important role in PM-induced cardiac oxidative
stress. Pharmacological inhibition of the ANS could signifi-
cantly reduce chemiluminescence in the heart after expo-
sure.303 More recently, an upstream modulator, the transient
receptor potential vanilloid receptor-1, within the lung was
identified as central to the inhaled CAP-mediated induction
of cardiac chemiluminescence.335 In these studies, capsaz-
epine was able to abrogate ECG alterations in rats during the
5-hour exposure, which suggests that neural ANS pathways
are crucial.
Thrombosis and Coagulation
Earlier studies using intratracheal instillation of high concen-
trations of diesel exhaust particles demonstrated the induction
of lung inflammation, platelet activation, and increased pe-
ripheral vascular thrombosis in both arteries and veins after
photochemical injury.336,337 Thrombosis susceptibility was
ascribed to direct passage of the instilled UFPs in the blood,
because large polystyrene particles unlikely to cross the
lung-blood barrier did not increase peripheral thrombosis. In
a subsequent study, a persistent increase in thrombosis
susceptibility to diesel exhaust particles was shown after 24
hours, an effect that was mitigated by pretreatment with
sodium cromoglycate, which indicates that this response was
secondary to histamine release from basophil degranula-
tion.338 These same effects, however, were mimicked by
400-nm polystyrene particles with a low likelihood of trans-
gressing the pulmonary barrier, which implicates pulmonary
release of histamine as a mediator of thrombosis at the later
time point. Because histamine was increased in the plasma at
6 and 24 hours after exposure, and diphenhydramine miti-
gated diesel PM–induced thrombosis at later time points but
not at 1 hour, it was hypothesized that additional direct effects
of PM constituents reaching the circulation may be respon-
sible for the earliest prothrombotic effects.339 No increase in
circulating von Willebrand factor was observed after instil-
lation of both particles. Finally, pulmonary instillation of
carbon nanotubes produced neutrophil lung influx 24 hours
later. Circulating platelet-leukocyte conjugates were elevated
6 hours after exposure, whereas procoagulant microvesicular
tissue factor activity and peripheral thrombotic potential were
increased 24 hours later. Inhibition of P-selectin abrogated
these responses, which demonstrates that rapid activation of
circulating platelets by the pulmonary deposition of PM plays
a vital role.340 This series of studies suggests that release of
lung cell–derived mediators (eg, histamine) after several
hours along with the more rapid activation of circulating
platelets by lung inflammation via P-selectin–dependent
processes may mediate distant system prothrombotic effects
without necessarily inducing systemic endothelial damage.
In a study using C57BL/6J mice, intratracheal PM10
particles rich in transition metals decreased bleeding, pro-
thrombin, and activated partial thromboplastin times and
enhanced the levels of several coagulation factors as well as
thrombosis times in response to experimental FeCl3 injury.316
This prothrombotic effect was mitigated in IL-6/ and
macrophage-depleted mice, which suggests that IL-6, lung
macrophages, and pulmonary inflammation are necessary
initial steps. It is possible, however, that coarse-particle
components (eg, endotoxin) could have been important mech-
anistically via TLR activation. The effect of fine PM or UFPs
per se requires more investigation. Chronic ambient exposure
to PM2.5 has also been shown to increase tissue factor
expression in macrophages and smooth muscle cells in
atherosclerotic lesions. Complementary in vitro studies with
cultured human smooth muscle cells and monocytes demon-
strate dose-dependent increases in tissue factor in response to
collected ambient particles.341 Other findings also support
potential procoagulant and thrombotic effects of PM.342,343
These collective studies suggest that both short- and long-
term PM inhalation can enhance thrombotic and coagulation
tendencies, potentially via increases in circulating histamine
and inflammatory cytokines and/or activated white cells and
platelets. The plausibility of these pathways is supported by
the well-recognized cross talk between inflammation and
thrombosis.344 Potential additional roles for UFPs or soluble
constituents that reach the circulation and directly enhance
platelet aggregation or systemic oxidative stress (thus acti-
vating the endothelium and blunting platelet-derived nitric
oxide) require more investigation.
Systemic and Pulmonary Hypertension
Early animal studies suggested small or inconsistent effects
of PM on BP,345–347 sometimes dependent on the season348 of
exposures. A potential explanation may be variations in
experimental protocols, including differences in the delivery,
duration, and composition of exposure and the methods used
to measure BP. Moreover, PM by itself may represent a
relatively weak stimulus but may act more robustly in concert
with other predisposing factors to affect BP. Sun et al333
recently demonstrated a significant interactive effect of fine-
CAP exposure with the vasoconstrictor angiotensin II in rats.
Preexposure to PM2.5 for a 10-week period resulted in
enhancement of its prohypertensive response measured con-
tinuously by intra-arterial radiotelemetry. The exaggerated
BP elevation was accompanied by endothelial dysfunction,
including blunted endothelium-dependent vasodilation and
enhanced vasoconstrictor reactivity, along with upregulation
of NAPDH oxidase and Rho-kinase–signaling pathways. In
vitro exposure to UFPs and PM2.5 was also associated with an
increase in Rho-kinase activity, phosphorylation of myosin
light chain, and myosin phosphatase target subunit. Pretreat-
ment with the nonspecific antioxidant N-acetylcysteine and
Rho-kinase inhibitors prevented these responses, which sug-
gests an ROS-mediated mechanism for particle-mediated
effects on vascular smooth muscle constriction. Further
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studies corroborated the role of exaggerated Rho-kinase
pathway activity in potentiating the hypertensive response to
angiotensin II in mice exposed to PM2.5.349 Moreover, parti-
cle exposure augmented angiotensin-mediated cardiac hyper-
trophy and collagen deposition. Blockade of Rho-kinase
abolished these effects. These responses suggest that chronic
PM2.5 exposure disrupts normal vascular homeostasis and
vasoactive mediator balance through ROS-dependent mech-
anisms in a manner that sensitizes the vessel toward vaso-
constrictors. Activation of RhoA/Rho-kinase signaling path-
ways appears to play an important mechanistic role.
In conscious canines with implanted BP catheters, systemic
arterial BP increased and baroreceptor sensitivity was rapidly
altered over a few hours during CAP exposure.350 Interest-
ingly, -adrenergic antagonism abrogated the responses. The
findings support a mechanistic role for acute activation of the
sympathetic nervous system by inhaled particles. In a study
with Wistar-Kyoto male rats, CAP exposure for 4 days
upregulated ET-A receptor expression in the heart. This
alteration was also weakly correlated with an increase in BP,
which suggests a role for enhance ET activity.351 PM has also
been demonstrated to alter the release of ET-1 and ET-3 from
the lungs.352 Elevation in pulmonary vascular resistance and
pulmonary arterial pressure, which suggests constriction of
the pulmonary vessels, has also been demonstrated in re-
sponse to respirable carbon black particles.353 Recently,
ultrafine carbon particles were shown to increase BP in
spontaneously hypertensive rats 1 to 3 days after a 24-hour
exposure.354 This response occurred concomitant with in-
creased ET-1 messenger ribonucleic acid levels in lung tissue
and small elevations in plasma renin concentration and
angiotensin I and II in the systemic circulation. These
findings further support the idea that ET may play a role in
cardiovascular responses to PM exposure and suggest that
activation of the renin-angiotensin system may also be
involved. It is not clear whether the elevated circulating ET
levels reflect increased release from the lungs and whether
this mediates a systemic vasoconstrictor response. Alterna-
tively, the increase may be more indicative of enhanced
vascular tissue activity of these systems. Longer-term expo-
sures of carbon black for 4 weeks in Sprague-Dawley rats has
also been shown to significantly increase systolic BP con-
comitant with increases in serum levels of IL-6 and CRP.355
Finally, in vitro exposure to soluble and insoluble compo-
nents of UFPs induces constriction in isolated pulmonary
arterial rings and activates intracellular signaling pathways
such as phosphorylation of extracellular signal–regulated
kinase-1/2 and p38 mitogen-activated protein kinase in pul-
monary endothelial cells. These effects were antagonized by
losartan, and several metal components (copper and zinc)
could replicate the responses.295 This suggests a possible role
for activation of angiotensin II receptor pathways relevant for
the maintenance of vasomotor tone and smooth muscle
constriction after inhalation of metal constituents within PM.
In sum, the studies demonstrate that long-term PM expo-
sures over a period of weeks are capable of enhancing
vasoconstrictive responsiveness of the vasculature (eg, in-
creased Rho-kinase activity and reduced nitric oxide bioavail-
ability) by inflammatory and ROS-dependent cell-signaling
pathways. Shorter-term exposures over several hours to days
may lead to vasoconstriction and increased pulmonary and
systemic BP by pathways dependent on enhanced ET or
angiotensin II signaling. Lung cells may release ET into the
systemic circulation and thus increase its systemic activity, or
the vascular ET system may be relatively upregulated be-
cause of increased ROS or reduced nitric oxide. Activation of
the renin-angiotensin system may also occur because of
systemic oxidative stress or inflammation or as a conse-
quence of ANS imbalance. The very acute increase in BP that
occurs concomitant with the inhalation of particles or within
only minutes to hours after exposure appears to be mediated
by autonomic imbalance that favors a relative activation of
the sympathetic nervous system. No study has evaluated the
effect of air pollution on renal sodium handling or long-term
pressure natriuresis mechanisms, which are fundamental to
the generation of chronic hypertension.
Vascular Dysfunction and Atherosclerosis
Many early experiments demonstrated the capacity of PM
constituents to blunt nitric oxide–dependent dilation and
enhance vasoconstrictor tone in ex vivo vascular studies
because of excess ROS formation.1 The first in vivo experi-
ment demonstrated the proatherosclerotic actions of intratra-
cheal PM10 instillation.356 More recently, the pulmonary
instillation of several different PM types was shown to
rapidly impair microvascular endothelium-dependent vasodi-
lation within days, likely by proinflammatory or ROS-
dependent mechanisms (eg, myeloperoxidase).332 Several
animal studies have now demonstrated that long-term expo-
sure to ambient PM2.5, by use of ambient-exposure facilities
without direct pulmonary instillation, not only causes endo-
thelial dysfunction but also accelerates the progression of
atherosclerosis. Sun et al334 demonstrated that exposure of
atherosclerosis-prone ApoE/ mice to environmentally rel-
evant levels of CAP, derived from regional northeastern
PM2.5, for 6 months in conjunction with a high-fat chow diet
potentiated plaque development and heightened vascular
inflammation (CD68 macrophage infiltration and inducible
nitric oxide synthase expression) and oxidant stress. The
atherosclerotic plaque progression was also accompanied by
alterations in vasomotor tone, including decreased endothe-
lium-dependent vasodilation and heightened vasoconstriction
to adrenergic stimuli. Importantly, the normalized average
PM2.5 concentration over the entire period was 15.2 g/m3,
which approximates the annual NAAQS. Similar findings
were reported in other chronic CAP exposures that involved
an ApoE/ model.357 However, exposures to a double-
knockout model of ApoE-deficient and low-density lipopro-
tein receptor–deficient mice increased plaque cellularity,
reflective of inflammation, but did not enhance plaque
burden. It is possible that the atherosclerotic severity of this
phenotype precluded the observation of more subtle effects of
CAP exposures.
Intratracheal instillation of UFP can acutely impair aortic
endothelium-dependent vasodilation.358 Moreover, repeated
10-week-long endotracheal dispersion of UFP carbon black
increased atherosclerosis in low-density lipoprotein receptor–
Brook et al Particulate Matter Air Pollution and CVD 2357
 by guest on M
arch 28, 2018
http://circ.ahajournals.org/
D
ow
nloaded from
 
knockout mice.359 This occurred without evidence of sys-
temic translocation of particles into the cardiovascular tis-
sues. UFP inhalation by use of exposure facilities has also
recently been shown to augment atherosclerosis, perhaps to a
greater degree than PM2.5. When investigating the effects of
different PM size fractions, Araujo et al331 compared the
proatherogenic potential of exposure over 40 days to ambient
particles 0.18 m versus PM2.5 in ApoE/ mice. UFPs
caused more adverse cardiovascular responses (eg, systemic
oxidative stress, impaired high-density lipoprotein function)
and greater potency in accelerating atherosclerotic lesion
formation, although PM2.5 did demonstrate qualitatively sim-
ilar effects. Recent studies have also demonstrated that PM
exposure likely promulgates systemic atherosclerosis by
mechanisms that overlap those of other conventional cardio-
vascular risk factors.360 Intratracheal instillation of PM10
particles caused a rapid impairment in endothelium-
dependent vasodilation, stimulation of bone marrow–derived
cells, and increased migration of monocytes into atheroscle-
rotic plaques.361,362 Systemic inflammation (IL-6) was also
related to the degree of endothelial dysfunction.314 Finally,
the most compelling evidence for rapid impairment in nitric
oxide bioavailability being directly involved in the origin of
PM-induced endothelial dysfunction was demonstrated re-
cently. Both fine-PM and UFM inhalation for only a few
hours in normal rats blunted agonist-stimulated nitric oxide
production within the microvasculature, measured by direct
electrochemical sensors, concomitant with an observed im-
pairment in vasomotor relaxation. Inhibition of myeloperox-
idase or NADP(H) oxidase partially restored normal nitric
oxide bioavailability and endothelial function, which suggests
a role of activation of these endogenous radical-generating
enzymes in this biological response.363
Potentially relevant adverse vascular effects of nonparticu-
late PM components should not be discounted. There may
also exist some synergy between vapor phase, gas, and
particle constituents in relation to instigation of cardiovascu-
lar responses. Recently,364 it was demonstrated in apoE/
mice that whole gasoline engine exhaust over 1 or 7 days
increased vascular messenger ribonucleic acid expression of
matrix metalloproteinase (MMP)-2 and MMP-9. Levels of
ET-1 and ROS were similarly increased. The vascular ROS
and MMP-2 elevations were attenuated by tempol. Endothe-
lial receptor antagonism ameliorated the vascular expression
of MMP-2, MMP-9, and ROS. In separate experiments,
diesel exhaust exposure to rats for 5 hours augmented
ET-induced vasoconstriction, potentially via a blunting of
ET-B–induced nitric oxide release.365 The findings suggest
that exposure to a fresh mixture of PM, gases, and vapors may
play a role in rapidly triggering atherosclerotic plaque vul-
nerability via ROS and ET-dependent upregulation of MMP
levels.
Some studies suggest that predisposed animals may be
more susceptible to air pollution–mediated vascular dysfunc-
tion. Diesel exhaust particles delivered by intraperitoneal
injection impaired nitric oxide–dependent vasodilation only
in apoE/ mice with atherosclerosis and not in healthy
control animals.366 Aortas from prediabetic rats were found to
be more susceptible to repeated exposures to oil combustion
particles in causing noradrenergic-mediated constriction and
impaired endothelium-dependent vasodilation.367
Taken together, the available studies suggest that short-
and long-term particle exposures (including PM10, PM2.5, and
UFP) can impair conduit and resistance arterial endothelium-
dependent vasodilation. Chronic exposures have been shown
to be capable of promoting atherosclerosis progression and
enhancing plaque vulnerability. The underlying mechanisms
likely involve vascular sequelae of systemic inflammation
(due to interactions with innate immune cells and cytokines)
or exaggerated oxidative stress pathways. Excess vascular
ROS and inflammation will impair endogenous vasodilator
bioavailability (eg, nitric oxide), enhance vasoconstrictor
tone (eg, ET), and chronically activate multiple intracellular
pathways that promote atherosclerosis.368–370
Heart Rate Variability
Some of the earliest indications of systemic effects of PM
came from ECG studies in rats.371 In general, reductions in
several measures of HRV have been shown.372–376 Most of the
recent research has focused on exploring the roles of suscep-
tibility and exposure characteristics. Decreases in heart rate
and HRV indices have been reported to be pronounced in
senescent mice, which indicates that aging may be a suscep-
tibility factor.353 Using an anesthetized model of postinfarc-
tion myocardium sensitivity, Wellenius and colleagues377 did
not demonstrate an effect of 1 hour of CAP exposure on heart
rate or spontaneous ventricular arrhythmias. In contrast, in a
post-MI heart failure model in Sprague-Dawley rats, diesel
exhaust emissions reduced HRV in both healthy and heart
failure groups and increased the incidence of premature
ventricular contractions. Studies in mice have also indicated a
potential role for transition metals and nickel in HRV
alterations376 and provide initial clues on the PM components
that could influence autonomic tone.48
Some beginning insight into the neural pathways involved
has been reported recently. PM-induced ECG changes in rats
were shown to be prevented by inhibiting the transient
receptor potential vanilloid receptor in the lungs. This sug-
gests that the relevant neural mechanism that leads to alter-
ations in HRV or heart rhythm may be induced by activation
of receptor-mediated autonomic reflexes in the lung.335 Cir-
culating particle constituents or inflammatory mediators in-
teracting with myocardial ion channels or electrophysiology
did not appear to be a pertinent mechanism, at least in these
studies.335 However, it is unknown whether similar mecha-
nisms can account for the HRV changes observed in humans,
and a more detailed understanding of the anatomic pathways
involved is required. Finally, it remains unclear whether the
changes in cardiac HRV are actually caused by or merely
illustrate an underlying alteration in ANS balance. Experi-
ments that clearly define the direct contribution of sympa-
thetic and parasympathetic nervous system activities (eg,
microneurography, norepinephrine spillover rates, or auto-
nomic receptor or ganglionic blockade) are needed.
MI and Arrhythmia
PM exposure can increase experimental infarct size and
potentiate myocardial ischemia and arrhythmias in experi-
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mental MI models. Relatively high concentrations of intra-
tracheal UFP instillation induced pulmonary inflammation
and doubled MI size in mice.358 Conscious dogs exposed to
fine CAP for several days experienced greater ST-segment
changes during transient coronary artery occlusion.378 These
studies suggested that particulate-related changes in myocar-
dial blood flow may be responsible, a hypothesis recently
supported by experiments in chronically instrumented dogs
exposed to fine CAP before transient occlusion of the left
anterior descending artery. PM exposure was associated with
a small but significant decrease in total myocardial flow,
especially in the ischemic zone, and increases in coronary
vascular resistance without an alteration in rate-pressure
product.379 The abnormalities were inversely related to PM
mass, particle number, and black carbon concentration.
Exposure to residual oil fly ash increases arrhythmia
frequency in rats with preexisting premature ventricular
complexes, which suggests that PM sensitizes ischemic
myocardium to abnormal automaticity372; however, CAP had
no effect in rats.380 Nevertheless, the data suggest that PM
exposure may potentially be capable increasing the sensitivity
of the myocardium to ischemia, likely by impairing myocar-
dial blood flow and perfusion. In theory, this could play a role
in enhancing the propensity for ventricular arrhythmias.
Insulin Resistance
Recently, Sun et al319 exposed C57BL/6 mice fed high-fat
chow to fine CAP or filtered air for 24 weeks. Mice exposed
to PM2.5 exhibited marked worsening of whole-body insulin
resistance, systemic inflammation (increased IL-6 and TNF-
), and higher levels of adipokines, such as resistin and
plasminogen activator inhibitor-1. PM2.5 increased visceral
adiposity and inflammation (F4/80 cells), with stromal
vascular cells expressing higher TNF- and IL-6 and lower
IL-10 levels. Exposure also induced insulin-signaling abnor-
malities and reduced phosphorylation of Akt and endothelial
nitric oxide synthase in aortic tissue, accompanied by abnor-
malities in vascular relaxation to insulin. Additionally, there
was evidence that PM2.5 exaggerated adhesion of monocytes
in mesenteric microvessels, culminating in accumulation in
visceral adipose. These intriguing findings suggest that
longer-term exposure to PM air pollution may promote the
chronic development of insulin resistance, obesity, and the
metabolic syndrome.
Controlled-Exposure Studies in Humans
Several new human exposure studies have been published, a
few of which have even included patients with CVD or risk
factors. Similar to the animal studies, large variations among
the exposure protocols, measured outcomes, and subject
susceptibilities likely explain much of the differences among
findings and must be considered when interpreting the results.
Systemic Inflammation
Controlled human exposure studies have measured the effects on
circulating inflammatory markers such as CRP, IL-6, and
TNF-. In many of these single-episode short-term exposures,
no overt changes in plasma cytokine levels were observed after
CAP381–383 or diesel exhaust.345,384–386 Similarly, CRP levels
have not consistently been found to increase in the time frame
and context of most of these studies.313,384–386
However, there have also been some positive findings.
Increases in IL-6313 and TNF- 24 hours after exposure to
diesel exhaust in healthy adults have been reported. High
levels of ambient particles can stimulate the bone marrow to
enhance the release of neutrophils, band cells, and monocytes
into the circulation, which causes a cellular inflammatory
response.387,388 Some controlled-exposure studies corroborate
the existence of a cellular proinflammatory response that
manifests as increases in circulating white blood cell or
immune cell counts. In 1 study, increased peripheral ba-
sophils in healthy older adults were noted 4 hours after a
2-hour exposure to fine CAP.389 In a similar study, increased
white blood cell counts were observed in healthy young
adults 12 hours after exposure.381 Recently, investigators
observed an increased in total white blood cell and neutrophil
levels immediately after a 2-hour exposure to CAP in
downtown Toronto, Ontario, Canada.390 Conversely, de-
creases in blood monocytes, basophils, eosinophils, and
CD54 and CD18 adhesion molecule expression on monocytes
after exposure to ultrafine carbon (10 to 50 g/m3) among
exercising asthmatic individuals and healthy adults have also
been reported.391 The authors suggested in the latter study
that these results may represent the sequestration of these
cells in tissue compartments such as the lung or vasculature,
where there may be selective expression of the corresponding
receptors for these ligands.362 However, other recent human
clinical studies have found no association between peripheral
blood cell counts and exposure to fine PM or UFPs such as
zinc oxide,392 ultrafine carbon,393 or diesel exhaust.313,384,385
More subtle, yet physiologically relevant or functional
proinflammatory changes may be overlooked by the measure-
ment of circulating cytokines or cell counts alone in human
studies. Peretz et al394 recently evaluated gene expression
using an expression array in monocytes after 2 hours of
exposure to diesel exhaust. Although initially a small study,
10 genes involved in the inflammatory response were mod-
ulated in response to exposure (8 upregulated, 2 downregu-
lated). These findings will need to be reproduced in larger
studies and raise the possibility that functional changes in
inflammatory cells may occur without discernible changes in
their levels in the peripheral circulation.394
In sum, the findings from controlled human exposures do
not demonstrate a robust inflammatory response; however,
they have been limited by the fact that they are, by necessity,
of short duration and relatively low concentration. Addition-
ally, the results do not preclude an effect of higher exposures,
the presence of more subtle responses, or alterations in other
cellular inflammatory pathways not measurable by circulat-
ing markers.
Systemic Oxidative Stress
The demonstration of systemic oxidative stress is difficult in
human studies. Nonetheless, a few studies have reported
positive findings. These include an increase in urinary excre-
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tion of free 8-iso-prostaglandin-2 among healthy adults after
a 4-hour exposure to concentrated wood smoke395 and an
increase in plasma antioxidant capacity 24 hours after a
1-hour exposure to diesel exhaust in a group of healthy
volunteers.313 The investigators speculated that systemic ox-
idative stress after exposure may have been responsible for
this upregulation in antioxidant defense.313 Other investiga-
tors394 have observed significant differences in expression of
genes involved in oxidative stress pathways due to diesel
exhaust exposure. Bra¨uner et al167 recently investigated the
effect of ultrafine traffic particles on oxidative stress–induced
damage to DNA in healthy young adults exposed to low
concentrations of ambient urban particles (PM2.5 and PM10–2.5
mass of 9.7 and 12.6 g/m3, respectively) in an exposure
chamber above a busy road with high traffic density. The
authors observed increased levels of DNA strand breaks and
formamidopyrimidine-DNA glycosylase sites in monocytes
after exposure to PM but no changes in the DNA repair
enzyme 7,8-dihydro-8-oxoguanine-DNA glycosylase. Simi-
lar to their previous findings with ambient levels,168 the
results suggest that short-term exposure to UFPs may result in
damage to DNA. This may occur through oxidative stress
pathways, although there was no increase in messenger
ribonucleic acid levels in heme oxygenase-1, a gene known to
be regulated by Nrf2, a transcription factor regulated by
oxidative stress.396 Moreover, more recent observations by
the same investigators failed to demonstrate significant bi-
omarker signals for lipid or protein oxidative damage after
similar near-roadway exposures.178 Although not entirely
consistent, the available studies demonstrate that acute expo-
sure to PM, perhaps even at ambient levels, may be capable
of inducing acute systemic oxidative stress in human subjects
under certain circumstances. The assays used to assess the
footprint of systemic “oxidative stress” or damage may also
play a significant role in the results.
Thrombosis and Coagulation
Several new studies of controlled human exposure have
evaluated the effects of PM on hemostatic markers (eg, factor
VII, fibrinogen, platelet count, D-dimer, and von Willebrand
factor). Although some of these studies have not observed
changes after acute exposures,392 others have reported in-
creases in fibrinogen levels at 8 to 24 hours after exposure to
CAP.381,397 Mills and colleagues384,385 recently demonstrated
a significant effect of diesel exhaust on fibrinolytic function
in response to intermittent exercise both in healthy men and
in men with coronary heart disease. In both groups of
volunteers, bradykinin-induced release of tissue plasminogen
activator was observed to decrease compared with filtered air
at 6 hours after exposure to diesel exhaust. These perturba-
tions in tissue plasminogen activator release did not persist 24
hours after exposure.313 In a randomized, controlled crossover
study involving “at-risk” metabolic syndrome patients, no
changes in plasminogen activator inhibitor-1 were noted over
a 24-hour duration; paradoxically, a decrease in von Wille-
brand factor was noted in this study.398 In a similar experi-
ment conducted in healthy adults, diesel exhaust had no effect
on D-dimer, von Willebrand factor, CRP, or platelet counts
compared with filtered air up to 22 hours after exposure.386
Other investigators395 recently evaluated the effect of wood
smoke on markers of coagulation, inflammation, and lipid
peroxidation in young healthy subjects. Serum amyloid A and
the ratio of factor VIII to von Willebrand factor, an indicator
of an increased risk of venous thromboembolism, were
increased at 4 hours after exposure.395 Samet et al383 reported
an association between various coagulation markers and
exposure to ultrafine, fine, and thoracic coarse CAP among
healthy young adults. Although exposure to coarse CAP did
not result in significant changes in hemostatic variables, the
overall trend suggested a prothrombotic effect. Exposure to
UFPs increased D-dimer levels, whereas fine-CAP effects
tended to increase fibrinogen, similar to previously reported
findings.381
The measurement of blood levels of coagulation factors or
biomarkers of thrombosis could potentially miss a relevant
biological effect at the vascular wall. Recently, ex vivo
thrombus formation was assessed by use of the Badimon
chamber after controlled exposures to dilute diesel exhaust in
healthy volunteers.399 This protocol measures thrombus for-
mation in native (nonanticoagulated) whole blood triggered
by exposure to a physiologically relevant substrate, under
flow conditions that mimic those found in diseased coronary
arteries. It may therefore provide a superior estimate of actual
in vivo conditions related to thrombosis potential. Interest-
ingly, dilute diesel exhaust exposure increased thrombus
formation within 2 hours, in association with increased
platelet activation (ie, increased circulating platelet-monocyte
aggregates and soluble CD40 ligand). Taken together, these
new studies have provided additional evidence that short-
term exposure to PM at near-ambient levels may have small
yet potentially significant effects on hemostasis in humans.
Whether direct interactions of circulating PM constituents
with platelets, activation of platelets due to lung inflammation
or secondary to elevated systemic cytokine levels, or an
increase in procoagulant factors (eg, fibrinogen) as an acute-
phase response to inflammation (or a combination of these
pathways) is responsible warrants attention in future studies.
Arterial BP
Although several studies have evaluated the BP response to
acute exposures, many inconsistencies in results have been
reported.400 This must be considered in the context that BP
was not the primary outcome of interest in most studies, nor
was it typically assessed with adequate sophistication. In one
of the earliest studies, PM2.5 increased systolic BP in healthy
subjects but decreased it in asthmatic individuals.401 Three
other controlled studies did not report changes among healthy
adults.345,402,403 However, in a more detailed reanalysis of the
changes in BP during the actual period of exposure to CAP
plus ozone, Urch et al404 found a significant increase in
diastolic BP of 6 mm Hg. The magnitude of response was
associated with the concentration of organic carbon within
PM2.5.405 Recent follow-up studies redemonstrated an acute
prohypertensive response during the inhalation of CAP in 2
separate cities.390 The PM2.5 mass during exposure and
decreases in several HRV metrics were associated with the
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magnitude of the short-lived diastolic BP elevation. This
suggested that the most plausible mechanism for this acute
response was CAP-induced ANS imbalance that favored
sympathetic over parasympathetic cardiovascular tone.
Whether this reaction occurred because of a generalized
stress response, as a consequence of specific soluble PM
constituents directly altering central nervous system activity,
or via altered ANS reflex arcs due to the interaction of inhaled
particles with lung receptors/nerve endings remains to be
elucidated.
The effect of inhaled particulates on BP has also been
investigated in several other recent controlled human expo-
sure studies. Two new studies assessed BP changes after a
1-hour exposure to diesel exhaust. Mills et al384 found a
6-mm Hg increase in diastolic BP 2 hours after exposure,
which was of marginal statistical significance (P0.08);
however, this trend did not persist for 24 hours,384 nor was it
found among patients with coronary artery disease.385 The
available data to date suggest that short-term exposure to
PM2.5 or diesel exhaust is capable in certain circumstances of
rapidly raising BP. The most consistent and largest effects
were seen concomitant with the inhalation of particles. Thus
far, the most likely mechanism for such rapid hemodynamic
responses appears to be ANS imbalance. However, it is
possible that reductions in nitric oxide bioavailability that
modulate basal arterial tone toward vasoconstriction or
increases in ET among other hemodynamically active
molecules (eg, angiotensin II) also play a role in some
circumstances.
Vascular Dysfunction
The first controlled human exposure study related to vascular
function reported that CAP plus ozone exposure caused acute
conduit arterial vasoconstriction in healthy adults.1 Endothe-
lium-dependent and -independent vasodilation remained in-
tact. Recent follow-up experiments determined that PM2.5,
not ozone, was responsible for the adverse vascular effects.
However, in these subsequent and larger experiments, fine-
CAP exposure did prove capable of diminishing conduit
artery endothelium-dependent vasodilation 24 hours (but not
immediately) after exposure.390 Postexposure PM2.5 mass and
TNF- level were both associated with the degree of endo-
thelial dysfunction, which suggests that systemic inflamma-
tion induced by higher levels of particles was likely respon-
sible. Finally, the CAP-induced endothelial dysfunction
occurred during exposures in Toronto, Canada, but not Ann
Arbor, Mich, which suggests that the composition of the
particles is probably an important determinant of the vascular
responses.
An acute alteration in vascular function/tone after short-
term controlled PM air pollution exposure was corroborated
recently.406 In 27 adults (10 healthy adults and 17 with the
metabolic syndrome), a 2-hour exposure to dilute diesel
exhaust caused a dose-dependent constriction of the brachial
artery and elevation in plasma ET level without impairing
endothelium-dependent vasodilation. Contrary to the hypoth-
esis that metabolic syndrome patients would show greater
effects, vasoconstriction was greater in magnitude among the
healthy participants. In an additional study, 2-hour exposure
to UFPs composed of elemental carbon impaired peak fore-
arm blood flow response to ischemia 3.5 hours later. There
were no other vascular changes or alterations at other time
points. BP was also not affected.407
Several recent studies have also shown that dilute diesel
exhaust can impair peripheral resistance vessel responses to
acetylcholine, bradykinin, and nitroprusside 6 hours after
exposure.384 The blunted responses to acetylcholine persisted
for 24 hours in healthy adults.313 In contrast, bradykinin and
sodium nitroprusside–mediated vasodilation and bradykinin-
induced acute plasma tissue plasminogen activator release
were not altered 24 hours later. In subsequent studies, patients
with stable coronary artery disease exposed to dilute diesel
exhaust for 1 hour during intermittent exercise demonstrated
reduced bradykinin-mediated tissue plasminogen activator
release; however, microvascular endothelial function was not
impaired.385 This may be related to some degree of preexist-
ing endothelial dysfunction in these patients. However,
exercise-induced ST-segment depression and ischemic bur-
den were significantly greater during diesel compared with
filtered air exposure. These important findings experimen-
tally highlight that PM air pollution exposure can trigger, or
augment existing, myocardial ischemia extremely rapidly (in
fact, concomitant with exposure). Reduced coronary flow
reserve (that was not observed or resolved at the time of the
postexposure brachial artery studies) due to rapid alterations
in coronary microvascular function may have contributed
to the acute myocardial ischemia. Alternatively, acute
ANS imbalance induced by diesel exhaust inhalation may
have acutely altered coronary tone and impaired myocar-
dial perfusion.
In a study that exposed healthy young adults to 100 g/m3
of diesel exhaust for 2 hours,364 it was recently demonstrated
that this air pollution mixture acutely raised plasma ET-1 and
MMP-9 expression and activity within 30 minutes. These
results corroborate the animal data that even short-term
exposures can rapidly alter factors, such as MMP activity,
that are mechanistically linked with causing atherosclerotic
plaque disruption (and thus acute MI). The increase in ET
levels also corroborates previous studies406 that showed that
diesel exhaust can acutely affect important endogenous reg-
ulators of vasomotor tone.
Controlled air pollution exposures have not always been
shown to impair endothelial function or vasomotor tone.
Despite an increase in exhaled 8-isoprostane concentrations
that suggested pulmonary oxidative stress, fine CAP did not
affect brachial flow–mediated dilation or basal diameter in
northern Scotland exposures.382 However, the PM2,5 con-
sisted of relatively inert ambient sea-salt particles and was
extremely low in combustion-derived sources. This is in
contrast to the particle chemistry in the investigators’ previ-
ous diesel exposure studies that showed positive find-
ings.408,409 Moreover, 24-hour exposure to ambient pollution
shunted into a chamber next to a busy street did not impair
microvascular endothelial function in 29 healthy subjects, as
assessed by digital tonometry.178 This exposure to near-
roadway ambient air, which consisted of ambient UFP and
PM2.5, did not alter biomarkers of inflammation, hemostasis,
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or protein and lipid oxidation. The authors speculated that the
relatively low concentrations of UFP numbers and PM mass
or the young, healthy status of the subjects could explain the
null findings. Taken together, these studies suggest that brief
PM exposure can trigger conduit arterial vasoconstriction,
possibly in relation to increased ET activity or augmented
sympathetic ANS tone. Under certain circumstances, conduit
and resistance arteriole endothelium-dependent vasodilation
can also be impaired within a few hours. This abnormality is
more likely due to reduced nitric oxide bioavailability as a
consequence of systemic proinflammatory and oxidative
responses; however, alternative mechanisms and endogenous
vasoactive pathways have not been fully explored. It is also
apparent that the composition, source, and concentration of
pollution, along with the susceptibility of the human subjects,
play important roles in determining the vascular effects of
acute air pollution exposure.
Heart Rate Variability
The results of several new controlled human exposure studies
provide limited evidence to suggest that acute exposure to
near-ambient levels of PM may be associated with small
changes in HRV. There are at least 4 studies to support this.
In the first study, healthy elderly individuals experienced
significant decreases in HRV immediately after exposure.233
Some of these changes persisted for at least 24 hours. Gong
et al410 studied healthy and asthmatic adults exposed to coarse
CAPs with intermittent exercise. HRV was not affected
immediately after the exposure but decreased in both groups
at 4 and 22 hours after the end of the exposure; greater
responses were observed in nonasthmatic individuals.410 In
another study, healthy elderly subjects and patients with
chronic obstructive pulmonary disease were exposed to ap-
proximately 200 g/m3 CAP and filtered air for 2 hours with
intermittent mild exercise. HRV over multihour intervals was
lower after CAP than after filtered air in healthy elderly
subjects but not in subjects with lung disease. A significant
negative effect of CAP on ectopic heartbeats during or after
CAP exposure relative to filtered air was noted in the healthy
subjects, whereas the group with pulmonary disease experi-
enced an improvement during or after CAP relative to filtered
air.389 Other investigators recently compared the effects of
2-hour exposures with intermittent exercise to ultrafine (av-
erage concentration 47 g/m3), fine (average concentration
120 g/m3), and coarse (average concentration 89 g/m3)
CAP among healthy subjects.383 In both the ultrafine and
coarse studies, a crossover design was used in which each
subject was exposed to both PM and filtered air. In the case
of the fine-PM study, subjects did not serve as their own
control but were exposed to either PM or filtered air. Thoracic
coarse fraction CAP produced a statistically significant de-
crease in the standard deviation of normal-to-normal heart
rate 20 hours after exposure compared with filtered air. No
statistically significant effects on HRV were observed after
exposure to UFPs as measured during controlled 5-minute
intervals. However, the authors did observe a significant
decrease in the standard deviation of normal-to-normal heart
rate after exposure to UFPs based on an analysis of the
24-hour measurements. No differences were reported in HRV
with fine-PM exposures. Although some controlled-exposure
studies have reported either no acute changes390 or, on
occasion, increases in HRV metrics in subsets of individu-
als,208,393,401 these studies generally demonstrate that acute
PM exposure is capable of reducing HRV. More consistent
reductions have been found among older adults (compared
with younger subjects or those with lung diseases, who show
mixed responses) and perhaps with exposures to larger parti-
cles.233,389 Whether pulmonary ANS reflex arcs are activated by
the deposition of PM within the lung or whether other pathways
are responsible for these physiological changes in human expo-
sure studies requires more investigation.
Evidence Summary and Contextual Framework for
Biological Mechanisms
Table 7 provides an outline of the level of evidence support-
ing the generalized intermediary pathways and specific mech-
anisms whereby PM exposures can be capable of eliciting
Table 7. Summary of Level of Evidence Supporting Global
Biological Pathways and Specific Mechanisms Whereby PM2.5,
Traffic-Related, or Combustion-Related Air Pollution Exposure
Can Affect the Cardiovascular System
Animal Studies Human Studies
General “intermediary”
pathways whereby PM
inhalation can instigate
extrapulmonary effects on
the cardiovascular system
Pathway 1: Instigation of
systemic proinflammatory
responses
111 111
Pathway 2: Alterations in
systemic ANS
balance/activity
1 11
Pathway 3: PM and/or
associated constituents
directly reaching the
systemic circulation
1 1
Specific biological
mechanisms directly
responsible for triggering
cardiovascular events
Vascular dysfunction or
vasoconstriction
111 11
Enhanced thrombosis or
coagulation potential
11 11
Elevated arterial BP 11 11
Enhanced atherosclerosis
or plaque vulnerability
11 1
Arrhythmias 1 1
The arrows are not indicators of the relative size of the association but
represent a qualitative assessment based on the consensus of the writing
group of the strength of the mechanistic evidence based on the number and/or
quality, as well as the consistency, of the relevant studies.
111 Indicates strong overall mechanistic evidence.
11 Indicates moderate overall mechanistic evidence.
1 Indicates some but limited or weak available mechanistic evidence.
Blank indicates lack of evidence.
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cardiovascular events. At the molecular level, oxidative stress
as a critically important cause and consequence of PM-
mediated cardiovascular effects has a sound experimental
basis.261,290b,294,319,333,334,345–349,351,361–364,411 At the integrated
physiological level, the collective body of evidence continues
to support the existence of 3 general pathways (Figure 3).
Some of these responses, such as systemic inflammation (via
pathway 1), likely require antecedent pulmonary oxidative
stress or inflammation in order to be initiated. Others,
including ANS imbalance (via pathway 2) and PM or its
constituents reaching the systemic circulation (via pathway
3), may not. Although PM-associated metals412 and certain
UFPs261,413–415 might be capable of translocating into the
blood stream, some studies have been negative in this
regard.355,416 Many issues related to this pathway are contro-
versial and require resolution.416 These include the relevance
of the dosages delivered to cardiovascular organs, the conse-
quences of particle constituent modifications after interac-
tions with lung tissue/fluids and plasma components, the
means of transport within the circulation (eg, protein bound
or within cells),417 and the time course and ultimate sites of
PM sequestration. It is also possible that increases in some
vasoactive mediators or molecules with adverse effects on
cardiovascular tissue, such as ET-1,351–354 may occur in the
lung and systemic circulation without the need for antecedent
lung inflammation. Moreover, the 3 general pathways repre-
sent a simplification of complicated biological processes.
They may not be mutually exclusive, may overlap tempo-
rally, and likely exhibit synergies in causing manifest cardio-
vascular disease events. Many of the biological pathways are
also known to exhibit mutual interactions (eg, inflammation
with thrombosis/coagulation and with autonomic function).
The pathways are also likely to be principally active at
differing time points (eg, more rapid cardiovascular effects of
autonomic imbalance than systemic inflammation) and likely
vary in importance in relation to different durations of
exposure and in causing different cardiovascular sequelae.
The chemical characteristics and sizes of inhaled PM may
also determine the pathways activated. As opposed to UFPs
or some particulate components or chemicals, larger fine and
coarse PM are not likely transported into the circulation to
any large degree and therefore are more apt to require
intermediary pathways to cause extrapulmonary effects. It
may also be that surface-bound components may be delivered
into the circulation, whereas larger particles themselves serve
as a means to deliver the responsible constituent into the
pulmonary tree.
The hyperacute physiological responses that occur minutes
to hours after PM inhalation are likely mediated principally
via pathways 2 and 3. These include ANS-mediated changes
(eg, elevated BP, arrhythmias, and vasoconstriction), along
with direct effects of circulating PM constituents on platelets
(eg, procoagulant and thrombotic changes) and the endothe-
lium (eg, oxidative stress and vasoconstriction). These re-
sponses are liable to be the dominant mechanisms responsible
for the actual triggering of acute cardiovascular events.
Clinically meaningful effects undoubtedly become manifest
only in the context of a susceptible patient, typified by the
individual with “vulnerable plaque” in the case of acute
coronary syndromes or strokes, “vulnerable myocardium” in
the context of arrhythmias, or the “vulnerable circulation” in
the context of a heart failure patient at risk for circulatory
overload. On the other hand, the biological consequences of
systemic inflammation, such as activated white cells and
elevated cytokines (via pathway 1), typically require longer
periods. Their penultimate effect is the induction of a chronic
underlying vulnerable milieu that leads to atherosclerotic
plaque vulnerability, enhanced coagulation/thrombotic and
arrhythmia potential, and impaired basal vasomotor balance.
These actions thereby predispose individuals for future car-
diovascular events, particularly when they occur in conjunc-
tion with traditional risk factors or prompt susceptibility to
the acute biological actions (via pathways 2 and 3) of later air
pollution exposures.
This hypothetical segregation of the biological effects of
PM exposure as acute or chronic and into the broad pathways
is artificial. It is useful in the broad context of understanding
potential pathways; however, there is no doubt a large degree
of overlap among the mechanisms and the timing of physio-
logical responses. This is most aptly conveyed as the influ-
ence of “acute on chronic” actions of exposure. For example,
the activation of circulating platelets by the pulmonary
deposition of particles or lung inflammation (eg, by P-
selectin–dependent pathways, histamine, or IL-6) could oc-
cur within hours and more rapidly than typical of the other
consequences of inflammation (eg, progression of atheroscle-
rosis). In the presence of a vulnerable or eroded coronary
plaque due to long-term air pollution exposure, this sudden
prothrombotic tendency could instigate an acute ischemic
event (alone or in conjunction with other effects of short-term
PM exposure via pathways 2 and 3). Furthermore, the
epidemiological cohort studies demonstrate a larger relative
risk for increased cardiovascular-related mortality than for
morbidity.72,73,227,274 If this is a true biological response and
not simply a statistical phenomenon or a shortcoming of the
available data, it not only suggests that exposures are capable
of triggering acute cardiovascular events but that PM air
pollution may also exaggerate their severity even if they
would have otherwise occurred for reasons unrelated to air
pollution. Therefore, exposure to PM could also be respon-
sible for promoting fatal over nonfatal events.
Conclusions and Recommendations
A wide array of new studies that range from epidemiology to
molecular and toxicological experiments have provided ad-
ditional persuasive evidence that present-day levels of air
pollutants contribute to cardiovascular morbidity and mortal-
ity. Although not unexpected given the numerous and hetero-
geneous nature of the published studies, all findings related to
every single cardiovascular end point have not been consis-
tent. However, the overall weight of scientific evidence now
supports several new conclusions since the 2004 statement.
These consensus points are given below by the AHA writing
group after considering the strength, consistency, and coher-
ence of the epidemiological findings, as well as in the context
of evaluating the extent of the studies that provided related
mechanistic support.
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● The preponderance of findings indicate that short-term
exposure to PM2.5 over a period of a few hours to weeks
can trigger CVD-related mortality and nonfatal events,
including myocardial ischemia and MIs, heart failure,
arrhythmias, and strokes.
● The increase in risk for acute PM2.5-associated cardiovas-
cular morbidity and mortality is principally among suscep-
tible, but not necessarily critically ill, individuals. Several
studies suggest that susceptible individuals at greater risk
may include the elderly, patients with preexisting coronary
artery disease, and perhaps those with diabetes. Recent data
suggest that women and obese individuals might also be at
higher risk.
● Most studies support the idea that longer-term PM2.5
exposures increase the risk for cardiovascular mortality to
an even greater extent than short-term exposures. Because
most studies have focused on mortality data, the effect of
long-term exposures on nonfatal cardiovascular events is
less consistent and requires more investigation.
● The PM2.5 concentration–cardiovascular risk relationships
for both short- and long-term exposures appear to be
monotonic, extending below 15 g/m3 (the 2006 annual
NAAQS level) without a discernable “safe” threshold.
● Long-term exposure to elevated concentrations of ambient
PM2.5 at levels encountered in the present-day environment
(ie, any increase by 10 g/m3) reduces life expectancy
within a population probably by several months to a few
years. Given that PM2.5 is most strongly associated with
cardiovascular deaths in the cohort studies, the reduced life
expectancy is most likely predominantly due to excess
cardiovascular mortality.
● The available studies are suggestive that reductions in PM
levels decrease cardiovascular mortality within a time
frame as short as a few years.
● Many potential biological mechanisms exist whereby PM
exposure could exacerbate existing CVDs and trigger acute
cardiovascular events (over the short term) and instigate or
accelerate chronic CVDs (over the long run). Experimental
support is increasingly strong for several mechanisms,
which lends biological plausibility for the epidemiological
findings.
● The existing evidence suggests that PM air pollution is
capable of augmenting the development and progression of
atherosclerosis. There is some support for a potential effect
on several other chronic CVDs, including hypertension,
heart failure, and diabetes.
● Most recent studies support the conclusion that the overall
absolute risk for mortality due to PM exposure is greater
for cardiovascular than pulmonary diseases after both
short- and long-term exposures.
There are several additional areas worthy of highlighting in
which the study results are reasonably consistent but in which
the writing group believed further research was required to
formulate firm conclusions.
● Although there is only limited epidemiological evidence
directly linking UFPs with cardiovascular health prob-
lems,262 the toxicological and experimental exposure evi-
dence is suggestive that this size fraction may pose a
particularly high risk to the cardiovascular system. The
likelihood of health effects and the causal pathways medi-
ated specifically by UFP exposure have been debated
among experts recently.418 Future research may help to
more fully elucidate whether particles within the ultrafine
size range (0.001 to 0.1 m) and/or their constituents are
more harmful to the cardiovascular system or pose a
relatively greater cardiovascular risk than particles between
0.1 and 2.5 m in diameter.
● Similarly, many studies have found a strong association
between metrics of traffic-related air pollution exposure
and elevated cardiovascular risk. Whether this represents
the harmful effects of UFPs or diesel exhaust particulates,
major components of the traffic mixture, or other pollution
components is unclear. Diesel and UFPs possess toxic
properties that instigate harmful biological responses in
experimental models. However, the particle size fraction(s)
and roles played by other copollutants (gases, VOCs,
SVOCs) within the traffic-related mixture have not been
fully elucidated. Nevertheless, traffic-related pollution as a
whole appears to be a specific source associated with
cardiovascular risk. It likely poses a major public health
burden, regardless of a putative higher toxicity, because of
the commonness of exposure in modern society (eg, ac-
counting for 60% of daily UFP exposure; http://
www.catf.us/projects/diesel/).
● The importance of other specific sources, regional differ-
ences in pollution composition, and other specific constit-
uents remains less clear. However, toxicological studies
have identified several transition metals (eg, iron, vana-
dium, nickel, copper, and zinc), organic carbon species,
semiquinones, and endotoxin as specific PM-related com-
ponents capable of prompting oxidative stress and inflam-
mation and thus likely imparting biological harm. Some
source-apportionment studies also demonstrate that atten-
tion should be given to these compounds as being among
the most likely mediators of clinical CVD. More studies are
required in this regard to clarify this issue and to better
define these and other potentially responsible constituents
and sources.
● Although the focus of the present statement is on PM, we
recognize that other air pollutants may also pose cardio-
vascular risk alone or in conjunction with fine-particle
exposure. In this context, we believe additional research is
necessary to make firm conclusions regarding the indepen-
dent cardiovascular risks posed by several gaseous pollut-
ants (eg, ozone and NO2). Although ozone has been linked
to increased cardiopulmonary mortality,50 strokes,126 and
MIs419 in some short-term studies, long-term exposure was
not associated with cardiovascular mortality after account-
ing for PM in a recent analysis.87 The recent finding that
small changes in low levels of ambient carbon monoxide
concentrations are related to cardiovascular hospitaliza-
tions also merits further exploration.420
● Several secondary aerosols (eg, nitrate and sulfate) are
often associated with cardiovascular mortality; however,
whether these compounds are directly harmful or are
surrogate markers of toxic sources of exposure requires
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more investigation. Similarly, the current literature re-
garding the independent cardiovascular risks posed by
coarse particles is mixed, with most recent findings not
supporting an association after accounting for the effects
of PM2.5.43,72,104
● Several recent cohort studies and intermediate end-point
experiments suggest that obese individuals (and/or those
with the metabolic syndrome) may be a susceptible popu-
lation at greater risk for cardiovascular events due to PM2.5
exposure. This is a tremendously important public health
issue to corroborate because of the enormous and growing
prevalence of obesity worldwide.
This updated review by the AHA writing group corroborates
and strengthens the conclusions of the initial scientific state-
ment. In this context, we agree with the concept and continue
to support measures based on scientific evidence, such as the
US EPA NAAQS, that seek to control PM levels to protect
the public health. Because the evidence reviewed supports
that there is no safe threshold, it appears that public health
benefits would accrue from lowering PM2.5 concentrations
even below present-day annual (15 g/m3) and 24-hour (35
g/m3) NAAQS, if feasible, to optimally protect the most
susceptible populations. Evaluations of the effectiveness of
such efforts would be warranted as well. Within the frame-
work of attempting to establish causality between associated
variables in epidemiological studies, there are several gener-
ally accepted “aspects” that have been evaluated (the follow-
ing phrases in italics per the Bradford Hill criteria)421: With
regard to cardiovascular mortality and PM2.5 exposure, there
is a consistent association that satisfies both a temporal and
exposure-response relationship. There is coherence of find-
ings among several fields of science, including toxicology,
human and animal exposures, and different types of epide-
miological studies and time frames of exposure. Rigorous
experiments demonstrate multiple plausible biological mech-
anisms. Finally, natural experiments have confirmed that a
change (ie, reduction) in exposure produces a change (ie,
decrease) in cardiovascular mortality. In this case, specificity
of outcomes and strength of the observation are less pertinent,
because PM exposure could be capable of causing multiple
different types of events (eg, MIs, arrhythmias, and heart
failure exacerbations), and the overall cardiovascular mortal-
ity relative risk posed for any single individual is expected to
be small. Nevertheless, given the ubiquity of exposure, the
overall public health consequences can be substantial and
observable in population- or large cohort–based studies.
It is the opinion of the writing group that the overall
evidence is consistent with a causal relationship between
PM2.5 exposure and cardiovascular morbidity and mortality.
This body of evidence has grown and has been strengthened
substantially since publication of the first AHA scientific
statement.1 At present, no credible alternative explanation
exists. These conclusions of our independent review are
broadly similar to those found in the EPA’s Integrated
Science Assessment for Particulate Matter final report (http://
cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid216546). In
summary, the AHA writing group deems that PM2.5 exposure
is a “modifiable factor contributing to cardiovascular mor-
bidity and mortality.”
Clinical Recommendations
Several precautionary recommendations can be made for
healthcare providers who interact with individuals who are at
risk for CVDs. Although they have not been clinically tested
or proven to reduce mortality, they are practical and feasible
measures that may help to reduce exposures to air pollution
and therefore potentially lower the associated cardiovascular
risk. Moreover, a recent observational study found that
patient awareness of air quality indices and media alerts along
with health professional advice can significantly affect re-
ported changes in outdoor activity to avoid exposure to air
pollution.422
● Evidence-based appropriate treatment of the traditional
cardiovascular risk factors should be emphasized. This may
also lessen the susceptibility of patients to air pollution
exposures.
● All patients with CVD should be educated about the
cardiovascular risks posed by air pollution.
● Consideration should also be given to educating patients
without CVD but who are at high risk (eg, the elderly,
individuals with the metabolic syndrome or multiple risk
factors, and those with diabetes).
● Part of patient education should include the provision of
information regarding the available sources (local and
national newspapers [USA Today], EPA World Wide Web
site [http://airnow.gov/], and The Weather Channel and its
World Wide Web site [http://www.weather.com/]) that
provide a daily EPA Air Quality Index.
● On the basis of the forecast Air Quality Index, prudent
recommendations for reducing exposure and limiting ac-
tivity should be provided based on the patient’s level of
risk. A list of such recommendations is provided on the
EPA World Wide Web site (http://airnow.gov/). For exam-
ple, when the Air Quality Index for PM is “unhealthy” (151
to 200), then the recommendations are as follows: “People
with heart or lung disease, older adults, and children should
avoid prolonged or heavy exertion. Everyone else should
reduce prolonged or heavy exertion.” The action recom-
mendations are as follows: “You can reduce your exposure
to particles by 1) planning strenuous activity when particle
levels are forecast to be lower, 2) reducing the amount of
time spent at vigorous activity, or 3) choosing a less
strenuous activity (eg, going for a walk instead of a jog).
When particle levels are high outdoors, they also can be
high indoors. Certain filters and room air cleaners are
available that can help reduce particles indoors.”
● Practical recommendations to reduce air pollution expo-
sure should be given to at-risk patients. Although
unproven to reduce cardiovascular events, there are a
number of prudent and feasible measures, including
reducing optional or unnecessary exposures. Additional
measures could include eliminating or reducing nonman-
datory travel to highly polluted regions and avoiding
exposures or outdoor activities (eg, exercising, commut-
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ing) during highly polluted times (eg, rush hours) or in
proximity to major sources of pollution (eg, roadways,
industrial sources). Choosing to exercise indoors with
windows closed and using efficient air conditioning and
filtering systems may be prudent for certain high-risk
patients, particularly during peak pollution periods.
Indeed, not only can central air conditioners reduce the
indoor exposure level to PM from outdoor sources, there
is some evidence that they might reduce the risk for
cardiovascular hospitalizations associated with higher
ambient pollution levels.423 If travel/commutes cannot
be avoided, maintaining optimal car filter systems,
driving with windows closed, and recycling inside ve-
hicle air may help reduce PM exposures (http://www.
catf.us/projects/diesel/).424,425
However, at present, no specific recommendations regarding
the appropriateness of undertaking more aggressive mea-
sures, even those shown to provide some benefits in a few
studies (eg, wearing facemasks, installing PM filters in
households), can be made based on the limited evidence.
Similarly, although measures that decrease long-term PM
exposures may produce even greater cardiovascular health
benefits than the provided recommendations that focus on
reducing short-term exposures, no specific recommendations
(eg, moving to less polluted regions) can be prudently made
at this time given the limited evidence. We acknowledge that
occupational and indoor sources along with secondhand
tobacco smoke are additional significant sources of personal
PM exposures that should be avoided or reduced as much as
possible. Finally, in developing nations, reducing exposure to
indoor cooking sources of PM and air pollution from biomass
combustion is a major issue of concern.426 Additional sug-
gestions are available on the EPA World Wide Web site.
Finally, although the existing evidence supports a causal
relationship between PM2.5 and cardiovascular mortality, we
acknowledge the importance of continued research in areas of
controversy and uncertainty to further understand the full
nature of this issue. Although numerous insights have greatly
enhanced our understanding of the PM-cardiovascular rela-
tionship since the first AHA statement was published,1 the
following list represents broad strategic avenues for future
investigation:
Mechanistic Studies
● Better describe the physiological relevance in humans and
the fundamental details of the mechanisms underlying the
intermediate general mediating pathways (ie, PM or con-
stituent transport into the circulation versus effects of
inflammatory cytokines or activated immune cells versus
ANS imbalance or other pathways) through which PM
inhalation might mediate cardiovascular effects remote
from the site of pulmonary deposition.
● Understand the clinical significance and relative impor-
tance of the observed biological responses (eg, vascular
dysfunction, thrombosis, arrhythmia, ANS imbalance) in
relation to the various causes of PM-mediated cardiovas-
cular morbidity and mortality.
● Examine the efficacy of preventive measures (eg, patient
education) and treatment modalities (eg, statins, antioxi-
dants, fish oil, treatment of traditional risk factors, and
reducing exposures by engineering controls, including
filtration, personal protection via facemasks, or behavior
modification) on cardiovascular health outcomes.
● Investigate the interaction between preexisting traditional
cardiovascular risk factors (eg, diabetes, hypertension) and
PM exposure, as well as the potential of air pollutants to
exacerbate or worsen these risk factors. Determine the
extent to which treatment of such factors (eg, with statins,
aspirin, or angiotensin-converting enzyme inhibitors), es-
pecially among patients with known CVD, may modify the
risk associated with PM exposure.
● Describe the biological effects of acute on top of chronic
exposures (eg, synergistic effects versus reduced susceptibility
to acute exposures due to augmented protective mechanisms).
● Determine the ability of long-term exposure to precipitate
the development of chronic diseases, including clinically
relevant atherosclerosis, hypertension, diabetes, and other
vascular, metabolic, renal, or neurological diseases.
Epidemiological and Exposure Studies
● Expand our knowledge related to the “responsible” PM
pollution constituents (eg, metals, organic compounds,
semiquinones, endotoxin, and VOC and SVOC compounds),
size fractions (eg, UFPs), sources (eg, traffic, power genera-
tion, and biomass combustion), and mixtures of pollutants.
● Investigate the cardiovascular health implications and im-
portance of regional and intracity differences in composi-
tion and combinations of pollutants.
● Better understand the effects of mixtures of ambient
pollutants (ie, potential synergism between PM and gas-
eous or vapor-phase pollutants such as ozone).
● Investigate the feasibility and utility of quantifying risk
coefficients (concentration-response functions) according
to PM source or relevant indices of pollutant mixtures, as a
function of susceptibility (eg, age, preexisting disease),
for reliable application in integrated, multipollutant risk
assessments.
● Investigate the relative importance of various time frames of
exposure in relation to PM causing cardiovascular events,
including the relevance of epochs not well described, such as
ultra-acute peak PM excursions (eg, 1 to 2 hours) and
exposures of intermediate duration (eg, 1 to 12 months).
● Better document the time course and specific cardiovascu-
lar health benefits induced by reductions in PM.
● Better define susceptible individuals or vulnerable
populations.
● Determine whether any “safe” PM threshold concentration exists
that eliminates both acute and chronic cardiovascular effects in
healthy and susceptible individuals and at a population level.
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